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Legal Disclaimer
The Guidelines for medical fitness to drive Sláinte agus Tiomáint (‘the Guidelines’) have been compiled by the Road 
Safety Authority in conjunction with the National Programme Office for Traffic Medicine* using all reasonable care and 
are based on expert medical opinion and relevant literature at the time of printing. A limited number of sections relating 
to diabetes, epilepsy vision and neurology disease and obstructive sleep apnoea syndrome as set by 2009/113/EC and 
2014/85/EU Directives (amending Directive 2006/126/EC) have the force of law implemented by regulations 12 and 20 of 
the Road Traffic (Licensing of Drivers) Regulations 2006, Statutory Instruments Number 537 of 2006, as amended by the 
Road Traffic (Licensing of Drivers) (Amendment) (No.) Regulations 2010, Statutory Instruments Number 544 of 2010. These 
will be marked with an EU Symbol in the Guidelines. Neither the Road Safety Authority nor the National Programme Office 
for Traffic Medicine nor the Royal College of Physicians of Ireland to which it is also associated accepts responsibility for 
any consequences arising from their application, including any liability in respect of any claim or cause of action arising 
out of, or in relation to, the use or reliance on the Guidelines.
Health professionals should keep informed of any changes in health care and health technology that may affect their 
assessment of drivers. They should also maintain an awareness of any changes in the law that may affect their legal 
responsibilities.
* The National Programme Office for Traffic Medicine was established as a joint initiative between the Road Safety Authority and the Royal College of Physicians of 
Ireland of Ireland in 2011.
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Foreword
Sláinte agus Tiomáint provides guidance on medical fitness for drivers and highlights the need for all of us to appreciate 
that the state of our health impacts, to a greater or lesser degree, on our ability to drive safely. Driver fitness is governed 
by EU law and regulations made in Ireland under the Road Traffic Acts. Sláinte agus Tiomáint is an interpretation of these 
laws; however, the Directive/regulations form the overriding legal basis for driver medical fitness in Ireland. 
 
One of the objectives of Sláinte agus Tiomáint is to promote mobility and to do this in a way that is consistent with safety 
on our roads. Once a driver is aware of any health aspects that impact on driving and follows the advice of their doctor, 
they can continue to drive in most cases.
Sláinte agus Tiomáint forms one part of a broader information and communication campaign to increase awareness 
among medical professionals and the wider public about fitness to drive. Sláinte agus Tiomáint was developed by the 
National Programme Office for Traffic Medicine which has been established as a joint initiative between the Road Safety 
Authority and the Royal College of Physicians of Ireland. In developing the Guidelines, the National Programme Office for 
Traffic Medicine engaged widely with stakeholders to ensure that they reflect good practice.
The Office also works to ensure that all doctors, healthcare disciplines, medical professionals, An Garda Síochána 
and transport professionals have training and support for the practical implementation of the guidelines on the ground. 
Sláinte agus Tiomáint is an important addition to the range of initiatives that ensures we can continue to drive safely 
on our roads.
Moyagh Murdock, CEO
Road Safety Authority
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Part A: General information
Chapter 1 
1 .0 Introduction
This publication summarises Irish medical guidelines of fitness to drive. The information in these Guidelines are intended 
to assist doctors and other healthcare professionals in advising their patients on fitness to drive, requirements for reporting 
to their National Driver Licence Service (NDLS)* and guidance on review of stability, progression or improvement of these 
conditions. It should be used by health professionals when:
• Treating any patient who holds a driver licence whose condition may impact on their ability to drive safely. The majority 
of adults drive, thus a health professional should routinely consider the impact of a patient’s condition on their ability 
to drive safely. Awareness of a patient’s occupation or other driving requirements is also helpful.
• Undertaking an examination at the request of NDLS:
– Assessing a person whose driving the NDLS believes may be unsafe (i.e. ‘for cause’ examinations).
– For licence renewal of an older driver.
This publication focuses on long-term health and disability-related conditions and their associated functional effects 
that may impact on driving. It sets out clear minimum medical requirements for licensing and forms the medical basis 
of decisions made by the NDLS. This publication also provides general guidance with respect to patient management for 
fitness to drive.
This publication is intended for use by any health professional who is involved in assessing a person’s fitness to drive 
including but not confined to: 
• medical practitioners (general practitioners (GP and other specialists) 
• optometrists 
• occupational therapists 
• psychologists 
• physiotherapists
• alcohol and drug addiction counsellors
These medical standards refer to Group 1 and Group 2 licence holders. The categories are outlined below.
These Guidelines are a part of a larger project of the National Programme Office for Traffic Medicine a joint initiative 
between the Road Safety Authority and the Royal College of Physicians of Ireland. This larger project will encompass the 
annual renewal and updating of Group 1 and Group 2 medical fitness to drive guidelines in conjunction with the delivery 
of education and research supports and developments such as conditional or restricted licences. The literature searches 
underpinning the annual review of the guidelines are available on the website of the National Programme Office for 
Traffic Medicine www.rcpi.ie/trafficmedicine
Group 1 Categories A, A1, A2, AM, B, BE, or W i.e. motorcycles, cars and tractors (with or without trailer).
Group 2 Categories C, CE, C1, C1E, D, DE, D1 or D1E i.e. truck and bus (with or without trailer).
The vehicles in Group 2 are regarded as higher-risk vehicles which require a higher standard of physical and mental 
fitness on the part of the driver.
Contact Details for Medical Fitness to Drive
Email: medicalfitness@rsa.ie
Website: www.ndls.ie
telephone no.: 1890406040
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1 .1 Traffic medicine and the compilation of the guidelines
Although the first automobile fatality in the world occurred in Ireland in 18591, Traffic Medicine is a relatively new specialism 
embracing all those disciplines, techniques, and methods aimed at reducing the harm traffic crashes inflict on human beings 
(International Traffic Medicine Association, 2009). There is also an enabling/rehabilitative element which tries to ensure 
that transport mobility (an important constituent of well-being and social inclusion) is not hampered, or rendered unsafe, 
by remediable illness or functional loss. 
It involves a wide range of disciplines, with a rapidly increasing research database which encompasses an active process of 
reflection, debate and consensus to maximise safe mobility. The most visible face of Traffic Medicine in most jurisdictions 
is the ‘medical fitness to drive’ aspect of driver licensing. Support for the approach of using evidence based guidelines is 
provided by evidence of a significant drop in crashes among drivers when such guidelines are systematically applied2. 
 
These Guidelines represent a synthesis of current research and clinical practice on medical fitness to drive as interpreted 
by the National Programme Office for Traffic Medicine, a joint initiative of the Road Safety Authority and the Royal College 
of Physicians of Ireland (see Acknowledgements). The contributors to the RCPI Working Group on Traffic Medicine includes 
virtually every medical specialty relevant to medical fitness to drive, as well as associated disciplines, the Irish Patients’ 
Association, the Garda S’och‡na and the Automobile Association. 
The Guidelines are based on four major sources of knowledge: i) Significant articles in the peer reviewed literature3;ii) 
Position papers by scientific organisations4; iii) National guidelines, particularly those of the UK Driver and Vehicle Licensing 
Agency, Australia’s Austroads, the Canadian Medical Association (CMA), the American Medical Association (AMA) as well 
as the US FMCSA Medical Examiner Handbook Information for Group 25; iv) the ‘grey’ literature including reports from the 
US Transportation Research Board, UK Transport Research Laboratory and other sources6. In addition, some key overview 
reports are used7 and the Directives of the European Union provide a legislative framework for some aspects, particularly 
vision, diabetes, epilepsy and sleep apnoea8. 
Annual syntheses of emerging research from medical databases are prepared each year and distributed to the Working Group 
and its sub-groups to aid in the deliberations on potential revisions of each section. The key search strategy is through the 
Medical SubHeading term “Automobile Driving” in the MedLine database, with allocation of the results to the various sections 
of the guide (see NPOTM website for 2014 searches). Given that any one recommendation may affect practice across many 
disciplines, the various aspects of medical fitness to drive are examined by various sub-groups (Vision, Substance Abuse, 
Diabetes, Cardiology, Psychiatry and Rehabilitation) but also by the whole Working Group.
1. Fallon I, O’Neill D. The world’s first automobile fatality. Accid Anal Prev 2005 Jul;37(4):601-3.
2. Redelmeier DA, Yarnell CJ, Thiruchelvam D, Tibshirani RJ. Physicians’ warnings for unfit drivers and the risk of trauma from road crashes.  
N Engl J Med. 2012 Sep 27;367(13):1228-36.
3. e.g. Laberge-Nadeau, Trucks and Diabetes, Diabetes Care, 2000;23:612-7; Hansotia P, Broste SK. The effect of epilepsy or diabetes on the risk of automobile 
accidents. N Eng J Med. 1991;324:22–26.
4. e.g. American Diabetes Association, Lorber D, Anderson J, Arent S, Cox DJ, Frier BM, Greene MA, Griffin JW Jr, Gross G, Hathaway K, Kohrman DB, Marrero DG, 
Songer TJ, Yatvin AL. Diabetes and driving. Diabetes Care. 2013 Jan;36 Suppl 1:S80-5; American Academy of Neurology, American Epilepsy Society, Epilepsy 
Foundation of America. Consensus statements, sample statutory provisions, and model regulations regarding driver licensing and epilepsy. Epilepsia. 
1994;35:696–705; Iverson, D.J., et al., Practice parameter update: evaluation and management of driving risk in dementia: report of the Quality Standards 
Subcommittee of the American Academy of Neurology. Neurology, 2010. 74(16): p. 1316-24. 
5. e.g. DVLA, https://www.gov.uk/government/publications/at-a-glance; Austroads, http://www.austroads.com.au/assessing-fitness-to-drive; / CMA, http:// 
www.cma.ca/ AMA, http://www.ama-assn.org/ama; FMCSA, http://nrcme.fmcsa.dot.gov/mehandbook/part_4_work_ep.aspx;
6. e.g. Medical Conditions and Driving: A Review of the Scientific Literature (1960–2000), Technical Report for the National Highway and Traffic Safety 
Administration and the Association for the Advancement of Automotive Medicine Project, Washington, TRB’s Conference Proceedings 27 -- Transportation in an 
Aging Society: A Decade of Experience. Washington DC, Transportation Research Board, 2004; Tunbridge, RJ,Keigan, M,James, FJ. The incidence of drugs and 
alcohol in road accident fatalities, Crowthorne, Transport Research Laboratory, 2001.
7. Vaa T. (2003) Impairment, Diseases, Age and Their Relative Risks of Accident Involvement: Results from Meta-Analysis, TØI Report 690 for the Institute of 
Transport Economics, Oslo, Norway; Charlton JL, Koppel S, Odell M, Devin A, Langford J, O’Hare M, et al. Influence of chronic illness on crash involvement 
of motor vehicle drivers. 2nd ed. Report 300.Victoria, Australia: Monash University Accident Research Centre; 2010; Available: www.monash.edu.au/miri/
research /reports/muarc300.html (accessed 2012 Oct. 10); Dobbs BM. (2005) DC; Marshall, Shawn C. (2008). The Role of Reduced Fitness to Drive Due to 
Medical Impairments in Explaining Crashes Involving Older Drivers. Traffic Injury Prevention, 9 (4), 291-298.
8. Directive 80/1263/EEC; Directive (91/439/EEC); Directive 2006/126; Directive 2009/113/EC; Directive 2014/85/EU.
2    Sláinte agus Tiomáint  |  Medical Fitness To Drive Guidelines  |  (Group 1 and Group 2 Drivers)
Údarás Um Shábháilteacht Ar Bhóithre
Road Safety Authority
The determination of the guidelines, and their annual review. is based on a number of factors, including likelihood of crash 
relating to factors associated with each illness, the importance of personal transport, fit with the practice and working of 
the Irish health services, European Union legislation and interdisciplinary perspectives. 
The perspective of both drivers and patients is incorporated through their review of the material processed through the 
Working Group: the incorporation of such perspectives is a topic which is not covered in the research literature on medical 
fitness to drive but thus far has been consensual in the development and review of the Irish guidelines. 
In addition, and consistent with good practice in guideline preparation9, external review of the guidelines is undertaken by an 
international expert in the field. Finally, the NPOTM also reviews the utility and applicability of the guidelines with end users10. 
The NPOTM is joint-funded by the Road Safety Authority and RCPI, the preparation and review process of these guidelines is 
editorially independent from both bodies. 
We are fortunate to be able to work with, and draw on the experience of, the UK Driver and Vehicle Licensing Authority 
(DVLA). The Irish Guidelines are to a very significant extent based on its At a Glance Guide to the current Medical Standards 
of Fitness to Drive, and some of the specialist contributors to the Guidelines are honorary members of the Advisory Panels 
of the DVLA. These Panels, which meet biannually, consist of doctors and other professionals eminent in the respective of 
cardiology, neurology, diabetes, vision, alcohol/substance misuse and psychiatry together with lay members. Consequently, 
both the Irish and UK standards are reviewed and updated regularly. 
Whilst every effort has been made to ensure the accuracy of the information contained, no guarantees can be given concerning 
the completeness or up-to-date nature of the information provided in these Guidelines, which are only accurate at the time 
of publication. Health Professionals should keep themselves up-to-date with changes in medical knowledge and technology 
that may influence their assessment of drivers, and with legislation that may affect the duties of the health professional or 
the driver. Therefore, neither the Road Safety Authority nor the National Programme Office for Traffic Medicine nor the Royal 
College of Physicians of Ireland accept liability whatsoever arising from errors or omissions in the Guidelines. 
It is also emphasised that the majority of these Guidelines are for use as guidance only, and should be viewed in the context 
of appropriate Continuing Professional Development on the topic of medical fitness to drive, as well as referral for appropriate 
specialist advice. However, a limited number, relating to diabetes, epilepsy vision ,neurological diseases and obstructive 
sleep apnoea syndrome, have the force of law, by virtue of the confirmation of the 2009 Directive and 2014 Directive into 
regulations 12 and 20 of the Road Traffic (Licensing of Drivers) Regulations 2006, Statutory Instruments Number 537 of 2006, 
as amended by the Road Traffic (Licensing of Drivers) (Amendment) (No .) Regulations 2010, Statutory Instruments Number 
544 of 2010 . These will be marked with an EU Symbol in the Guidelines .
9.  Rapoport MJ, Weegar K, Kadulina Y, BŽdard M, Carr D, Charlton J, Dow J,Gillespie I, Hawley C, Koppel S, McCullagh S, Molnar F, Murie-Fern‡ndez M, Naglie  
G, O’Neill D, Shortt S, Simpson C, Tuokko H, Vrkljan B, Marshall S. AnInternational Study of the Quality of National-Level Guidelines on Driving with  
Medical Illness. QJM. 2015 Feb 5. pii: hcv038. [Epub ahead of print] PubMed PMID:25660605.
10.  Kahvedžic A, Mcfadden R, Cummins G, Carr D, O’Neill D. Impact of new guidelines and educational programme on awareness of medical fitness to drive  
among general practitioners in Ireland. Traffic Inj Prev. 2014 Oct 30:0. [Epubahead of print]
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2 .0 Roles and responsibilities
Table 1: Roles and responsibilities of drivers, health professionals and driver licensing authorities
Driver
• To report to the National Driver Licence Service (NDLS) and their insurance provider any long-term or permanent 
injury or illness that may affect their ability to drive without elevated risk: if holding a licence from an EU country 
other than Ireland, or a recognised country for licence exchange, and developing a condition which could elevate 
risk of impairment while driving, the driver must contact the NDLS to arrange for an exchange of their licence.
• To respond truthfully to questions from the health professional regarding their health status and the likely impact 
on their driving ability.
• To adhere to prescribed medical treatment and monitor and manage their condition(s) and any adaptations 
with ongoing consideration of their fitness to drive.
• To comply with requirements of their licence as appropriate, including periodic medical reviews.
Health professional 
• To assess the person’s medical fitness to drive based on the current Sláinte agus Tiomáint medical standards.
• To advise the person regarding the impact of their medical condition or disability on their ability to drive and 
recommend restrictions and ongoing monitoring as required.
• To advise the person of their responsibility to report their condition to the NDLS if their long-term or permanent 
injury or illness may affect their ability to drive.
• To treat, monitor and manage the person’s condition with ongoing consideration of their fitness to drive.
• To report to the NDLS regarding a person’s fitness to drive in the exceptional circumstances where there is a risk 
to the public and the driver cannot or will not cease driving.
National Driver Licence Service (NDLS)
• To make all decisions regarding the licensing of drivers. The NDLS will consider reports provided by health 
professionals.
• To inform the driving public of their responsibility to report any long-term or permanent injury or illness to the 
NDLS if the condition may affect their ability to drive safely.
• Will act on reports of third parties, Gardaí, general public and healthcare workers regarding concerns of public 
safety relating to medical fitness to drive.
2 .1 Roles and responsibilities of the NDLS
The responsibility for issuing, renewing, suspending, withdrawing, refusing or cancelling a person’s driving licence lies 
ultimately with the NDLS. Licensing decisions are based on a full consideration of relevant factors relating to the driver’s 
health and driving performance record. In making a licensing decision, the authority will seek input regarding a person’s 
medical fitness to drive, either directly from the driver and/or from a health professional by way of D501 Medical Report. 
Where appropriate, the authority will also consider unsolicited reports from health professionals or the police regarding 
a person’s fitness to drive. Payments for health examinations or assessments related to fitness to drive are not the 
responsibility of the NDLS.
An appeals mechanism is available for drivers who have been refused a licence on medical grounds. The NDLS will 
inform drivers of the appeals process when informing them of the licensing decision.
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2 .2 Roles and responsibilities of drivers
Irish and EU legislation requires that a driver should advise the NDLS of any long-term or permanent injury or illness that may 
elevate risk of impairment while driving.
Regulations 12 and 20 of the Road Traffic (Licensing of Drivers) Regulations 2006, Statutory Instruments Number 
537 of 2006, as amended by the Road Traffic (Licensing of Drivers) (Amendment) (No. 2) Regulations 2010, Statutory 
Instruments Number 544 of 2010, give effect to Commission Directives regarding medical criteria for certification 
of fitness to drive, in particular relating to diabetes, epilepsy vision, neurological diseases and obstructive sleep 
apnoea syndrome.
At licence application and renewal, drivers complete a declaration regarding their health, including whether they have 
any relevant medical conditions from a list of 23 medical conditions. As advised on the Driver Application/Renew Form, 
when the listed medical conditions are present the NDLS requests that a medical examination is required to confirm a 
driver’s fitness to hold a driver licence. In the case of medical examinations requested by the NDLS, drivers have a duty 
to declare their health status to the examining health professional. Drivers are also required to report to the NDLS when 
they become aware of a health condition that may affect their ability to drive safely.
A driver should not drive while medically unfit to do so and can be convicted of an offence for doing so. Under Sections 
32 and 48 of the Road Traffic Act 1961, drivers should be aware that there may be long-term financial, insurance and 
legal consequences where there is failure to report a medical condition that may impact on their ability to drive safely 
to the NDLS and insurance provider. Drivers must adhere to prescribed medical treatment and monitor and manage their 
condition(s) and any adaptations with ongoing consideration of their fitness to drive.
2 .3 Roles and responsibilities of health professionals
Drivers rely on health professionals to advise them if a permanent or long-term injury or illness could elevate risk 
of impairment while driving, and whether it should be reported to the NDLS. The health professional has an ethical 
obligation, and potentially a legal one, to give clear advice to the driver in cases where an illness or injury may elevate 
risk of impairment while driving, and to maximise health and function so as to facilitate ease and driving safety. In the 
case of an incident illness which may affect driving ability, it is the responsibility of the healthcare professional attending 
the patient for the relevant care episode to advise the patient on medical fitness to drive.
There may be options other than complete cessation of driving where a driver presents with a particular condition, a 
restriction such as a modified braking system can be coded on the driving licence allowing for safer mobility. In the future 
the RSA will be providing for additional codes which will include a code for restricting driving to daytime only. Health 
professionals are advised to note in the medical record the nature of the advice given.
When what appears to be dangerous driving, possibly related to medical fitness to drive issues, is reported to a healthcare 
professional by a third party, it is a misguided kindness to pursue an exclusively medical approach. Dangerous driving is 
a hazard to the driver and other road users and is a statutory offence so people who witness dangerous driving should 
report it immediately to the Gardaí – a useful number is the Traffic Watch lo-call number 1890 205 805. Unless witnessed 
by the healthcare professional directly, the onus for reporting lies with the person witnessing the alleged dangerous 
driving. The medical issues can be pursued at a later stage.
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Underlying the professional obligation to manage risk and fitness to drive, there is also a professional and moral obligation 
to recognise and support mobility through appropriate diagnosis, treatment and support, as the consequences of driving 
cessation can lead to serious health, mobility and quality of life concerns as well11.
2 .3 .1 Confidentiality, privacy and reporting to the NDLS
Health professionals have both an ethical and legal duty to maintain patient confidentiality. The ethical duty is generally 
expressed through codes issued by professional bodies. The legal duty is expressed through legislative and administrative 
means, and includes measures to protect personal information about a specific individual. The duty to protect confidentiality 
also applies to the NDLS. The patient–professional relationship is built on a foundation of trust. Patients disclose highly 
personal and sensitive information to health professionals because they trust that the information will remain confidential. 
If such trust is broken, many patients could either forego examination/treatment and/or modify the information they 
give to their health professional, thus placing their health at risk.
Although confidentiality is an essential component of the patient–professional relationship, there are, on rare occasions, 
ethically and/or legally justifiable reasons for breaching confidentiality. With respect to assessing and reporting fitness 
to drive, the duty to maintain confidentiality is legally qualified in certain circumstances in order to protect public safety. 
The Irish Medical Council Guidelines provide for breach of confidentiality if the driver represents a risk to the safety of 
others, refuses or cannot inform the NDLS, fails to stop or adapt driving appropriately, and is not amenable to appropriate 
persuasion and discussion. The health professional should consider reporting directly to the NDLS in situations where 
the driver is:
• Unable or unwilling to appreciate the impact of their condition which is impacting on their fitness to drive;  
and is 
• Unable or unwilling to take notice of the health professional’s recommendations; and
• Continues driving despite appropriate advice and is likely to endanger the public.
If the situation is urgent and rises outside of normal NDLS working hours and in the opinion of the health professional is 
likely to prove a significant threat to the public, consideration should be given to inform the Gardaí.
A positive duty is imposed on health professionals to notify the relevant authority in writing of a belief that a driver is 
physically or mentally unfit to drive, poses a risk to public safety and is not compliant with professional advice to stop 
driving. It is preferable that any action taken in the interests of public safety should be taken with the consent of the 
driver wherever possible and should certainly be undertaken with the driver’s knowledge of the intended action to the 
greatest extent possible. The driver should be fully informed as to why the information needs to be disclosed to the NDLS, 
and be given the opportunity to consider this information. Failure to inform the driver will only exacerbate the driver’s 
(and others’) mistrust in the patient–professional relationship.
It is recognised that there might be an occasion where the health professional feels that informing the driver of the 
disclosure may place the health professional at risk of violence. Under such circumstances, the health professional must 
consider how to appropriately manage such a situation. In making a decision to report directly to the NDLS, it may be 
useful for the health professional to consider:
• The seriousness of the situation (i.e. the immediate risks to public safety).
• The risks associated with disclosure without the individual’s consent or knowledge, balanced against the implications 
of non-disclosure.
• The health professional’s ethical and professional obligations.
• Whether the circumstances indicate a serious and imminent threat to the health, life or safety of any person.
11.  Oxley, J., & Whelan, M. (2008). It cannot be all about safety: the benefits of prolonged mobility. Traffic injury prevention, 9(4), 367-378
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Examinations requested by the NDLS 
When a driver presents for a medical examination at the request of the NDLS, the situation is different with respect to 
confidentiality. The driver will present with a form or letter from the NDLS, requesting an examination for the purposes of 
licence application or renewal. In the future the completed form will generally be returned by the driver to the NDLS, thus 
there is no risk of breaching confidentiality or privacy, provided only information relevant to the driver’s driving ability is 
included on the form, and a copy of the form/report should be retained by the assessing clinician.
Privacy legislation
All health professionals and the NDLS should be aware of data protection and other applicable legislation when collecting 
and managing patient information and when forwarding such information to third parties.
2 .3 .2 Patient–health professional relationship
It is expected that the health professional will be able to act objectively in assessing a patient’s fitness to drive. If this 
cannot be achieved, for example, where there may be the possibility of the patient ceasing contact or avoiding all medical 
management of their condition, health professionals should be prepared to disqualify themselves and refer their patient 
to another practitioner.
2 .3 .3 Adverse patient reaction towards the health professional
Sometimes patients feel affronted by the possibility of restrictions to their driving or withdrawal of their licence, and may 
be hostile towards their treating health professionals. In such circumstances, the health professional may elect to refer 
the driver to another practitioner or may refer them directly to the NDLS without a recommendation regarding fitness 
to drive with the former being the preference of the NDLS, as a completed D501 Medical Report is required in such cases 
to inform the licensing decision. The NDLS recognise that it is their role to enforce the laws on driver licensing and road 
safety and will not place pressure on health professionals that might needlessly expose them to risk of harassment or 
intimidation. In addition guidelines of the medical council on hostile and violent behaviour i.e. Guide to professional 
conduct and ethics for registered medical practitioners’ s.14.1 should be considered. In addition, particularly for conditions 
such as dementia where insight may be reduced, helpful guides are available for the manner in which such conversations 
may be managed by doctors, families and patients from the Hartford Foundation http://hartfordauto .thehartford .com/UI/
Downloads/Crossroads .pdf and the Alzheimer Society of Ireland http://www .alzheimer .ie/Alzheimer/media/SiteMedia/
Helpline%20and%20Information%20Resources/pwd%20resources/Driving-and-dementia_FactSheet_web .pdf
2 .3 .4 Dealing with individuals that are not regular patients
Care should be taken when health professionals are dealing with drivers who are not regular patients. Some drivers may 
seek to deceive health professionals about their medical history and health status, and may ‘doctor shop’ for a desirable 
opinion. If a health professional has doubts about an individual’s reason for seeking a consultation, they should consider:
• Asking permission from the individual to request their medical file from their regular health professional.
• Conducting a more thorough examination of the individual than would usually be undertaken.
2 .4 Role of the consultant including specialist occupational physician
In most circumstances, medical assessments of drivers can be conducted by a GP. However, if doubt exists about a patient’s 
fitness to drive or if the patient’s particular condition or circumstances are not covered specifically by the standards, 
review by a consultant experienced in the management of the particular condition is warranted and the GP should refer 
the patient to such a specialist.
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If in doubt about the patient’s suitability to drive, referral to a further specialist and associated multi-disciplinary team 
(i.e. physiotherapy, occupational therapy, psychology, optometry) and/or on-road testing with a driving assessor qualified 
to assess driving among those with disabilities may be of assistance. 
The consultant or specialist occupational physician  should advise the driver’s GP on the fitness to drive or otherwise 
relating to their specialist area of expertise. This would enable the GP to complete the D501 based on their assessment 
of the overall health of the driver, as well as incorporating the specialist opinion.
The D501 is the form in general use for all medical conditions: the D502 is used at original licence application, and if 
through medical or surgical intervention the driver’s vision improves to the point that corrective lenses, previously specified 
on a driving licence application, are no longer needed.
2 .4 .1 Documentation
Clear documentation of the assessment results and communication with the patient and NDLS is important, as well as 
maintenance of a record of decisions and advice given to the driver. D501 (Medical Reports) or D502 (Eyesight Reports)are 
only accepted by NDLS if printed and signed as double-sided documents. The D501 (Medical Report) and  D502 (Eyesight 
Report) forms are available for download at www.ndls.ie and www.rsa.ie. Where there is any doubt about how to complete 
the D501 (Medical Report) or D502 (Eyesight Report) forms please review the guide on our websites.
To aid the documentation of the assessment process, a Patient Advisory Form is available on the RSA and NDLS website 
that provides written information that can be given to the patient and it is also advisable to keep this form on file.
3 .0 General considerations for assessing fitness to drive
The aim of determining fitness to drive is to achieve a balance between minimising any driving-related road safety risks 
for the individual and the community posed by the driver’s permanent or long-term injury or illness, and maintaining 
the driver’s lifestyle and employment-related mobility independence. Indeed, for many conditions, remediation and 
rehabilitation may improve driver comfort and safety.
The following pages outline the general principles and considerations for assessing driver fitness. Also included in this 
section is a summary of the assessment process. These principles should be considered in conjunction with the specific 
standards outlined in Part B of this publication.
3 .1 Considerations for Group 2 licensing
The assignment of medical standards for vehicle drivers is based on an evaluation of the driver, passenger and public 
safety risk, where risk = likelihood of the event x severity of consequences. 
Group 2 vehicle crashes may present a severe threat to passengers, other road users (including pedestrians and cyclists) 
and residents adjacent to the road. Such crashes present potential threats in terms of weight and height, spillage of 
chemicals, fire and other significant property damage. 
Group 2 vehicle drivers generally spend considerable time on the road, thus increasing the likelihood of a motor vehicle 
crash. Crashes involving Group 1 drivers are likely to have less severe consequences. 
Therefore, to ensure that the risk to the public is similar for Group 1 and Group 2 vehicle drivers, the medical fitness 
requirements for the latter must be more stringent. This is required in order to reduce to a minimum the risk of crash due 
to long-term injuries or illnesses. The standards outlined in this publication reflect these differences. 
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In developing the standards, a number of approaches have been adopted to manage the increased risk associated with 
driving a Group 2 vehicle. These approaches include:
• There are generally longer non-driving periods prescribed for Group 2 vehicle drivers compared with private vehicles, 
for example, after a seizure or heart attack.
Licensing and medical fitness to drive
• Some medical conditions may preclude a person from driving a Group 2 vehicle but they may still be eligible to hold 
a full or short period licence for a private vehicle, for example, early dementia.
Note:
In such cases, both sets of standards may need to be consulted. The standards are intended for application to drivers who 
drive within the ambit of ordinary road laws. Drivers who are permitted to exceed these laws, such as emergency service 
vehicle drivers, should have a risk assessment and an appropriate level of medical standard applied, as determined by 
the relevant occupational health service.
The review period for a short period licence for a Group 2 vehicle driver is 1, 3 or 5 years.
Group 2 standards are minimum standards and do not preclude employers setting higher standards in terms of the 
demands of driving and other tasks encountered in the course of employment.
3 .2 Requirements of the driving task
Consideration of the requirements of the driving task is fundamental to assessing a person’s medical fitness to drive. The 
driving task involves a complex and rapidly repeating cycle that requires a level of skill and the ability to interact with both 
the vehicle and the external environment at the same time. Information about the road environment is obtained via the 
visual and auditory senses. The information is operated on by many cognitive and behavioural processes including short 
and long-term memory and judgement, which leads to decisions being made about driving. Decisions are put into effect 
via the musculoskeletal system, which acts on the steering, gears and brakes to alter the vehicle in relation to the road.
The overall process is co-ordinated via a complex process involving behaviour, strategic and tactical abilities and personality12 
and adaptive strategies are important in maintaining the normal parameters of driving safety in the face of illness and 
disability13. This repeating sequence depends, among other elements, on:
• vision
• visuospatial perception
• hearing
• attention and concentration
• memory
• insight
• judgement
• adaptive strategies
• reaction time
• planning/organisation
• ability to self monitor
• sensation
• muscle power
• co-ordination
Given these requirements, it follows that many body systems need to be functional in order to ensure safe and timely 
execution of the skills required for driving.
12. Fuller R. Towards a general theory of driver behaviour. Accid Anal Prev 2005;37(3):461-72.
13. Langford J, Braitman K, Charlton J, Eberhard J, O’Neill D, Staplin L, Stutts J. TRB Workshop 2007: Licensing authorities’ options  
for managing older driver safety practical advice from the researchers. Traffic Inj Prev 2008;9(4):278-81.
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Table 2: Environmental factors affecting driving performance
Driving tasks occur within a dynamic system influenced by complex driver, vehicle, task, organisational and 
external road environment factors including:
• The driver’s experience, training and attitude.
• The driver’s physical, mental and emotional health, including fatigue and the effect of prescription and non 
prescription (over the counter) medicines.
• The driver’s insight, self-regulation of health and driving, and prudence
• The road system, for example, signs, other road users, traffic characteristics and road layout.
• Legal requirements, for example, speed limits and blood alcohol concentration.
• The natural environment, for example, night, extremes of weather and glare.
• Vehicle and equipment characteristics, for example type of vehicle, braking performance and maintenance.
• Personal requirements, trip purpose, destination, appointments, time pressures etc.
• Passengers and their potential to distract the driver.
• If the Group 2 driver is employed by a company, it may be helpful for the assessing doctor to ask the patient 
for a copy of the specifics of driving task and its nature and extent as identified and evaluated under his/her 
employer’s risk assessment process.
3 .3 Medical conditions likely to affect fitness to drive
Given the many causal factors in motor vehicle crashes, the extent to which medical conditions contribute is difficult to 
assess. There is, however, recognition of the potential for certain conditions to cause serious impairments. 
In general, this can occur through three different pathways: 
• Suddenly disabling events
- i.e., syncope, epilepsy, ICDs…
• Physical constraints 
- i.e., Parkinsonism, hemiplegia, vision…
• Impairment of self-regulation
- i.e., imprudence, psychiatric illness, cognitive impairment…
And a driver may present with a condition or conditions relevant to these pathways due to conditions such as:
• blackouts
• cardiovascular diseases
• diabetes
• musculoskeletal conditions
• neurological conditions such as epilepsy, dementia and cognitive impairment due to other causes
• psychiatric conditions
• substance misuse/dependency
• sleep disorders
• vision problems
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9. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical educa-
tion: a cross-sectional study. Lancet. 2012 Jul 7;380(9836):37-43.
Treatments for medical conditions (including drug treatments and others) can also affect driving ability positively or 
negatively.
Drivers may present to treating health professionals with a range of conditions, some that affect driving temporarily, or 
may affect the driver’s ability to drive at some time in the future, or that are complicated by the presence of multiple 
conditions. The content of this publication focuses on common conditions known to affect fitness to drive and, in particular, 
on determining the risk of a patient’s involvement in a serious vehicle crash caused by loss of control of the vehicle.
It is accepted that other medical conditions or combinations of conditions may also be relevant and that it is not 
possible to define all clinical situations where an individual’s overall function would compromise public safety. A degree 
of professional judgement, with more extensive assessment or specialist opinion as required, is therefore required in 
assessing fitness to drive.
Should a clinician require further assessment of a driver (for example, occupational therapy specialist opinion or
on-road test), the doctor in charge of their care should be able to advise the driver whether or not it is appropriate for them 
to continue to drive during the period until these further assessments have been completed. Drivers may be reminded that 
if they choose to ignore medical advice to cease driving, there could be consequences with respect to their insurance cover.
3 .4 Temporary conditions
There is a wide range of conditions that temporarily affect the ability to drive safely. These include conditions such as 
post major surgery, severe migraine, or injuries to limbs. These conditions are self-limiting and hence do not impact 
on licence status; therefore, the NDLS need not be informed. However, the treating health professional should provide 
suitable advice to such driver’s regarding driving safely. Such advice should be based on consideration of the likely 
impact of the driver’s condition and their specific circumstances on the driving task as well as their specific driving 
requirements. Table 3 provides guidance on some common conditions that may temporarily impact on driving ability. 
Note: this publication does not attempt to address every condition or situation that might temporarily affect safe 
driving ability. For conditions not specifically mentioned relevant clinical specialist advice may need to be invoked. 
See following table for examples of management of temporary conditions.
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Condition and impact on driving
Anaesthesia
Physical and mental capacity may be impaired for some 
time post anaesthesia (including both general and local 
anaesthesia). The effects of general anaesthesia will 
depend on factors such as duration of anaesthesia, the 
drugs administered and the surgery performed. The effect 
of local anaesthesia will depend on dosage and the region 
of administration. The use of analgesics and sedatives 
should also be considered.
Post surgery
Surgery will impact on driving ability to varying degrees 
depending on the location, nature and extent of the 
procedure.
Pregnancy
Under normal circumstances pregnancy should not be 
considered a barrier to driving. However, conditions that 
may be associated with some pregnancies should be 
considered when advising patients. These include:
• Fainting or light-headedness.
• Hyperemesis gravidarum.
• Hypertension of pregnancy.
• Post caesarean section.
Temporary or short-term vision impairments
A number of conditions and treatments may impair vision 
in the short term, for example, temporary patching of 
an eye, use of mydriatics or other drugs known to impair 
vision, or eye surgery. For long-term vision problems, refer 
to Part B, Chapter 7, Vision and eye disorders.
Deep vein thrombosis and pulmonary embolism 
While deep vein thrombosis may lead to an acute pulmonary 
embolus there is little evidence that such an event causes 
crashes. Therefore there is no licensing standard applied to 
either condition. Non-driving periods are advised.
Management guidelines
In cases of recovery following surgery or procedures under 
general or local anaesthesia, it is the responsibility of the 
surgeon/dentist and anaesthetist
to advise patients not to drive until physical and mental 
recovery is compatible with driving safety.
• Following minor procedures under local anaesthesia 
without sedation (e.g. dental block), driving may be 
acceptable immediately after the procedure.
• Following brief surgery or procedures with short- 
acting anaesthetic drugs, the patient may be fit to 
drive after a normal night’s sleep.
• After longer surgery or procedures requiring general 
anaesthesia, it may not be safe to drive for 24 hours 
or more.
The non-driving period post surgery should be determined 
by the treating health professionals.
A caution regarding driving may be required depending 
on the severity of symptoms and the expected effects 
of medication.
People whose vision is temporarily impaired by a short-
term eye condition or an eye treatment should be advised 
not to drive for an appropriate period.
The non-driving period after stable or anticoagulation 
should be determined by the treating health professionals. 
Table 3: Examples of management of temporary conditions
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3 .5 Undifferentiated conditions
A driver may present with symptoms that could have implications for their licence status but the diagnosis is not clear. 
Investigation of the symptoms will mean there is a period of uncertainty before a definitive diagnosis is made and before 
the licensing requirements can be confidently applied.
Each situation will need to be assessed individually, with due consideration being given to the probability of a serious 
disease or long-term or permanent injury or illness that may affect driving, and to the circumstances in which driving is 
required. However, patients presenting with symptoms of a potentially serious nature, for example, chest pains, dizzy 
spells or black-outs, or delusional states should be advised not to drive until their condition can be adequately assessed. 
During this interim period, in the case of private vehicle drivers, no formal communication with the NDLS is required. After 
a diagnosis is firmly established and the standards applied, normal notification procedures apply, if needed. The health 
professional should consider the impact on the driver’s livelihood and investigate the condition as quickly as possible.
3 .6 Multiple conditions and age-related change
Where a vehicle driver has multiple conditions or a condition that affects multiple body systems, there may be an additive 
or a compounding detrimental effect on driving abilities, for example, in:
• Congenital disabilities such as cerebral palsy, spina bifida and various syndromes.
• Multiple trauma causing orthopaedic and neurological injuries as well as psychiatric sequelae.
• Multi-system diseases such as diabetes, connective tissue disease and HIV.
• Dual diagnoses involving psychiatric illness and drug or alcohol addiction.
• Ageing-related changes in motor, cognitive and sensory abilities together with degenerative disease.
• Fatigue related to cancer and neurological conditions.
Although these medical standards are designed principally around individual conditions, clinical judgement is needed 
to integrate and consider the effects on safe driving of any medical conditions and disabilities that a driver may present 
with. For example, glaucoma may cause a slight loss of peripheral vision. If combined with cervical spondylosis and low 
insight, there is likely to be a substantial reduction in the driver’s visual fields and possibly their perceptual abilities, thus 
increasing the risks of missing important visual information when driving.
Advanced age, in itself, is not a barrier to driving, and functional ability rather than chronological age should be the criterion 
used in assessing the fitness to drive of older people, although physicians should be mindful that multi- morbidity increases 
with age14. Age-related physical and mental changes vary greatly between individuals but will eventually affect the ability 
to drive safely. Professional judgement must determine what is acceptable decline (compensated by the driver’s long 
experience and self-imposed limitations on when and where they drive) and what is irreversible, hazardous deterioration 
in driving-related skills, requiring reporting to the NDLS. This may require careful consideration and specialist referral: 
options include specialist medical referral, occupational therapy assessment, and an on-road assessment.
As all possible combinations of disabilities are too numerous to detail here, the following guidelines provide a general 
approach to assessing these drivers:
The driving task: 
First, consider the ergonomics of the driving task. How might the various impairments (sensory, cognitive and 
musculoskeletal), disabilities and general fitness levels impact on function required to complete driving-related tasks?
General functionality:
Consider to what extent the person is currently able to function with regard to domestic or occupational requirements 
and what compensatory or coping strategies may have been developed. Information gained from relatives or carers is 
also likely to be important in this regard. Individuals may be likely to cope better with congenital or slow-onset conditions 
compared with traumatic or rapidly developing conditions.
14. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical  
education: a cross-sectional study. Lancet. 2012 Jul 7;380(9836):37-43.
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Clinical assessment:
The key considerations are:
• Cognition (including attention, concentration, presence of hallucinations and delusions, insight, judgement, memory, 
problem-solving skills, thought processing and visuospatial skills).
• Motor function (including joint movements, strength and co-ordination).
• Sensory (in particular visual acuity and visual fields but also cutaneous, muscle and joint sensation).
It may be necessary for the health professional to consider medical standards for each condition. However, it is insufficient 
simply to apply the medical standards contained in this publication for each condition separately, as a driver may have 
several minor impairments that alone may not affect driving but when taken together may make risks associated with 
driving unacceptable. It will, therefore, be necessary to integrate all clinical information, bearing in mind the additive or 
compounding effect of each condition on the overall capacity of the driver to control the vehicle, and to act and react in 
an appropriate and timely way to emergent traffic and road conditions.
Capacity to learn to drive: 
Young people with multiple disabilities may seek the opportunity to gain a driving licence. In order to ensure they receive 
informed advice and reasonable opportunities for training, it is helpful if they are trained by a driving instructor with 
experience in the area of teaching drivers with disabilities.
Occupational therapy assessment:
A referral for an assessment by a generalist occupational therapist may be useful. It could request an evaluation of overall 
functioning (personal, mobility, community and work activities) as well as seek an opinion on general capacity for driving.
On-road driving assessment:
An on-road assessment may also be helpful.
In light of the information given above, the health professional may advise the driver regarding their fitness to drive and 
provide advice to the NDLS. The key question is: Is there a likelihood the person will be unable to control the vehicle and 
act or react appropriately to the driving environment in a safe, consistent and timely manner?
Where one or more conditions are progressive, it may be important to reduce driving exposure and ensure ongoing monitoring 
of the driver. The requirement for periodic reviews can be included as recommendations. This is also important for drivers 
with conditions likely to be associated with future reductions in insight and self-regulation. If lack of insight may become 
an issue in the future, it is important to advise the driver to report the condition(s) to the NDLS.
3 .7 Progressive disorders
Often diagnoses of progressive disorders are made well before there is any need to question whether the driver remains 
safe to drive (e.g. multiple sclerosis). However, it is advantageous to raise issues relating to the likely effects of these 
disorders on personal independent mobility early in the management process so as to facilitate future planning, and 
possible eventual driving cessation and sourcing of alternative transportation.
In a mobile society, people frequently make choices about employment, place of residence and recreational and social 
activities based on the assumption of continued access to a car. Changing jobs, home and social contacts takes a great 
deal of time and places substantial emotional demands on drivers and their families.
It is, therefore, recommended that the driver be advised appropriately where a progressive condition is diagnosed that 
may result in future restrictions on driving. It is important to give the driver as much lead time as possible to make the 
lifestyle changes that may later be required. Assistance from an occupational therapist may be valuable in such instances.
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3 .8 Congenital conditions
People with congenital or childhood conditions may have developed coping strategies that enable safe driving despite their 
impairment. They will require individual assessment by a Specialist and may need tutoring prior to a practical assessment. 
While they may require specific vehicle modifications, if the condition is static they may not require periodic reviews.
3 .9 Medications and driving
The definition of prescription medications for the purpose of these Guidelines is recommended as: Licensed medical 
product for human use requiring to be used in accordance with a prescription or medical product for human use 
requiring it to be used in accordance with prescription or medical or healthcarer (including pharmacist) advice.
Any medication that acts on the central nervous system has the potential to adversely affect driving skills, although it 
must be also recognised that many medications, such as antiparkinsonian medications, anti-inflammatory agents and 
antidepressants, may actually make driving safer and more comfortable.
Central nervous system depressants, for example, may reduce vigilance, increase reaction times and impair decision making 
in a very similar manner to alcohol. In addition, medications that affect behaviour may exaggerate adverse behavioural 
traits and introduce risk-taking behaviours. Group 2 drivers need to be mindful that such effects may be considered to be 
included in the Safety, Health and Welfare at Work Act (2005) s.13 (b) which stipulates that “employees must...ensure…
that he or she is not under the influence of an intoxicant to the extent that he or she is in such a state as to endanger his 
or her own safety, health or welfare at work or that of any other person.”
Acute impairment due to alcohol or drugs (including illicit, prescription and over-the-counter drugs) is managed through 
specific road safety legislation that prohibits driving over a certain blood alcohol concentration (BAC) or when impaired by 
drugs. This is a separate consideration to long-term medical fitness to drive and licensing, thus specific medical requirements 
are not provided in this publication. Dependency and substance misuse, including chronic misuse of prescription drugs, 
is a licensing issue and standards are outlined in Chapter 6. 
Where medication is relevant to the overall assessment of fitness to drive in the management of specific conditions, 
such as diabetes, epilepsy and psychiatric conditions, this is covered in the respective chapters. Prescribing doctors and 
pharmacists do however, need to be mindful of the potential effects of all prescribed and over-the-counter medicines and 
to advise drivers accordingly. General guidance is provided below.
3 .9 .1 General guidance for prescription medicine and driving
While many medicines have effects on the central nervous system most, with the exception of benzodiazepines, tend not to 
pose a significantly increased crash risk when the medicines are used as prescribed, and once the driver is stabilised on the 
treatment . This may also relate to drivers’ self-regulating their driving behaviour. When advising patients and considering 
their general fitness to drive, whether in the short or longer term, health professionals should consider the following:
• The balance between potential impairment due to the medicine and the driver’s improvement in health on safe 
driving ability.
• The individual response of the patient - some individuals are more affected than others.
• The type of licence held and the nature of the driving task, i.e. Group 2 vehicle driver assessments should be more 
stringent.
• The added risks of combining two or more medicines capable of causing impairment, including alcohol.
• The added risks of sleep deprivation on fatigue while driving, which is particularly relevant to Group 2 vehicle drivers.
• The potential impact of changing medications or changing dosage.
• The cumulative effects of medications.
• The presence of other medical conditions that may combine to adversely affect driving ability.
• Other factors that may exacerbate risks, such as known history of alcohol or drug misuse.
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For individual medicinal products, the summary of product characteristics (SmPC) and patient information leaflet (PIL) 
may be a useful source of information on the impact of these products on driving safety. SmPCs and PILs can be found 
on the IMB website: www.imb.ie.
Liaison between prescribing doctors and pharmacists is encouraged in the consideration of advice given to drivers taking 
medications which may impact on driving safety. 
3 .9 .2 The effects of specific medicine classes
For the following psychoactive medications, the driver should be advised about concerns over sedation while initiating
and changing treatment, and that driving should cease if such signs are noted: resumption should only recommence
when such sedating side-effects have ceased .
Benzodiazepines
Benzodiazepines, particularly long-acting benzodiazepines, increase the risk of a crash. In many of these cases, 
benzodiazepines were either abused or used in combination with other impairing substances. If a hypnotic is needed, a 
shorter-acting medicine is preferred. Tolerance to the sedative effects of the longer-acting benzodiazepines used in the 
treatment of anxiety gradually reduces their adverse impact on driving skills.
Antidepressants
Although antidepressants are one of the more commonly detected drug groups in fatally injured drivers, this tends to 
reflect their wide use in the community. The ability to impair is greater with sedating tricyclic antidepressants, such as 
amitriptyline and dosulepin, than with less sedating serotonin reuptake inhibitors, such as fluoxetine and sertraline, and 
the mixed reuptake inhibitors. However, antidepressants can reduce the psychomotor and cognitive impairment caused 
by depression and return mood towards normal. This can improve driving performance.
Antipsychotics
This diverse class of drugs can improve performance if substantial psychotic-related cognitive deficits are present. However, 
most antipsychotics are sedating and have the potential to adversely affect driving skills through blockade of central 
dopaminergic and other receptors. Older drugs such as chlorpromazine are very sedating due to their additional actions 
on the cholinergic and histamine receptors. Some newer drugs are also sedating, such as clozapine, olanzapine and 
quetiapine, while others such as aripiprazole, risperidone and ziprasidone are less sedating. Sedation may be a particular 
problem early in treatment and at higher doses.
Opioids
There is little direct evidence that opioid analgesics such as hydromorphone, morphine or oxycodone have direct adverse 
effects on driving behaviour14. Cognitive performance is reduced early in treatment, largely due to their sedative effects, 
but neuroadaptation is rapidly established. This means that drivers on a stable dose of an opioid may not have a higher 
risk of a crash. This includes drivers on buprenorphine and methadone for their opioid dependency, providing the dose 
has been stabilised over some weeks and they are not abusing other impairing drugs. Driving at night may be a problem 
due to the persistent miotic effects of these drugs reducing peripheral vision.
Medicinal Cannabis
The Health Products Regulatory Authority (successor to the Irish Medicines Board) authorised, in July 2014, by issue of a 
product license, an approved human medicine containing the active ingredients of cannabis which may be prescribed as 
treatment for symptom improvement in adult patients with moderate to severe spasticity due to multiple sclerosis (MS). 
The therapeutic indication is for patients with MS who have not responded adequately to other anti-spasticity medication 
and who demonstrate clinically significant improvement in spasticity related symptoms during an initial trial of therapy. 
Medicinal cannabis may impair judgment and performance of skilled tasks. Research however suggests that drivers adapted 
to their medicinal dose generally, but not always, maintain their driving ability15 . Drivers should be advised about potential 
effects of the medication on their driving and also advised to self-monitor accordingly for any indications of impairment 
of driving particularly when they first start to take the medication and until they are established on a stable daily dose.
14. Mailis-Gagnon A, Lakha SF, Furlan A, Nicholson K, Yegneswaran B, Sabatowski R. Systematic review of the quality and generalizability of studies on the effect-
sof opioids on driving and cognitive/psychomotor performance. Clin J Pain. 2012 Jul;28(6):542-55.
15. Freidel, M., et al. “Drug resistant MS spasticity treatment with Sativex¨ add-on and driving ability.” Acta Neurologica Scandinavica (2014).
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4 .0 The legal basis for the medical standards
Since January 2013 the Road Safety Authority is the licensing authority with the responsibility of ensuring that all licence holders 
are fit to drive. The legal basis of fitness to drive arises from the Road Traffic (Licensing of Drivers) Regulations 2006, Statutory 
Instrument Number 537 of 2006, as amended which provide for the medical standards in EU Directive 2006/126 as amended. 
(See table to follow).
Table 4: Legal considerations for licensing
• NDLS processes following medical advice
 Driving licences are issued or maintained by the NDLS on the basis that the driver has not been advised to cease 
driving by a doctor or healthcare professional on the basis of clinical assessment and the advice contained within 
these Guidelines. Should a driver be advised to cease driving by a doctor or healthcare professional on the basis 
of clinical assessment and the advice contained within these Guidelines, he/she should inform the NDLS if so 
indicated in these Guidelines. It is then a matter for the NDLS to take appropriate action.
• Appeals
 Decisions about the granting of a driving licence are a matter for the NDLS and arrangements concerning the 
review or appeal against such decisions should be taken up with the NDLS.
• Age limits
 Group1 Licences are normally issued for a 10 year period subject to expiry at age 70 years, unless restricted to a 
shorter duration for medical reasons. There is no upper limit but after age 70 renewal is necessary every 3 years, 
or every year if medical assessment so indicates. All licence applications after 70 currently require a medical 
report furnished by the applicant. Group 2 licences are issued for a maximum of 5 years up to the age of 70.
• Garda/Army driver licensing
 Responsibility for determining the standards, including medical requirements, to be applied to Garda/Army 
vehicle drivers, rests with the Garda Commissioner/Army Director of Services.
• Taxi drivers
 The provision of driving licences for small public service vehicles is the responsibility of An Garda Síochána. 
Responsibility for determining the standards, including medical requirements, to be applied to taxi drivers, 
over and above the Group 1 driving licence requirements, rests with the National Transport Authority, who are 
required to consult with the Garda Commissioner in relation to such proposals.
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Part B: Medical fitness to drive  
Chapter 2
Neurological disorders16
Group 2 standards are minimum standards and do not preclude employers setting higher standards in terms of the 
demands of the driving tasks encountered in the course of employment.
Neurological Disorders Group 1 - Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Epilepsy
Epileptic attacks are the most 
frequent medical cause of 
collapse at the wheel.
N .B . If within a 24 hour period 
more than one epileptic attack 
occurs, these are treated as a 
“single event” for the purpose of 
applying the epilepsy standards. 
Epilepsy includes all events: 
major, minor and auras.
The epilepsy standards apply . 
Provided a licence holder/
applicant is able to satisfy the 
standards, a 3 year licence 
will be issued normally by the 
NDLS. Before age 70 a person 
must be seizure-free for 5 
years to qualify for a 10 year 
licence in the absence of any 
other disqualifying condition. 
Fit to drive if seizure-free for 
5 years since the last attack, 
with medication if necessary 
in the absence of any other 
disqualifying condition. 
(See appendix to this chapter  
for full standards). 
Driver must notify NDLS.
Standards require a driver to remain 
seizure-free for 10 years since the 
last attack without antiepileptic 
medication.
The applicant should:
• be without anti-epileptic 
medication for the required 
period of seizure freedom. 
• have appropriate medical 
follow-up completed. 
• after extensive neurological 
investigation, have no 
relevant cerebral pathology 
established and there is no 
epileptiform activity on the 
electroencephalogram (EEG). 
• have an EEG and an appropriate 
neurological assessment should 
be performed after the acute 
episode. 
Driver must notify NDLS.
See Appendix at end of this chapter for epilepsy standards.
16. Helpful recent reviews include: Devlin, A, et al. (2012). Epilepsy and driving: Current status of research. Epilepsy Research, 102, 135— 152.  
Classen, S., et al., (2009). Traumatic brain injury and driving assessment: an evidence-based literature review [Review]. American Journal of Occupational 
Therapy, 63(5), 580-591.Klimkeit, E.I, et al., (2009). Driving ability in Parkinson’s Disease: Current status of research. Neuroscience & Biobehavioral Reviews, 33, 
223-231.Breen DA, Breen DP, Moore JW, Breen PA, O’Neill D. Driving and dementia. BMJ 2007 Jun 30;334(7608):1365-9.Peeters SY, Hoek AE, Mollink SM, Huff JS. 
Syncope: risk stratification andclinical decision making. Emerg Med Pract. 2014 Apr;16(4):1-22
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See Appendix at end of this chapter for epilepsy standards.
Neurological Disorders Group 1 - Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
First unprovoked seizure 6 months off driving from 
the date of the seizure unless 
there are clinical factors or 
investigation results which, 
in the opinion of the treating 
consultant suggest an 
unacceptably high risk of a 
further seizure, i.e. 20% or 
greater per annum.
Driver must notify NDLS.
5 years off driving from the date of 
the seizure if the licence holder has 
undergone recent assessment by a 
neurologist and there are no clinical 
factors or investigation results (e.g. 
EEG, brain scan) which indicate 
that the risk of a further seizure is 
greater than 2% per annum. They 
should have taken no antiepileptic 
medication throughout the 5 year 
period immediately prior to the 
granting of the licence.
Driver must notify NDLS.
If risk of further seizure is greater 
than 2% per annum Group 2 
epilepsy standards apply.
The following features are consistent with a person having a good prognosis:
• No relevant structural abnormality of the brain on imaging;
• No definite epileptiform activity on EEG;
• Clinical evaluation of the neurologist;
• Seizure risk considered to be 2% or less per annum for Group 2 licensing and 20% or less per annum for 
ordinary driving licensing.
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See Appendix at end of this chapter for epilepsy standards.
Neurological Disorders Group 1 - Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Epilepsy/epileptic seizures
General guidance for all 
neurosurgical conditions if 
associated with epilepsy or 
epileptic seizures.
In all cases where epilepsy has 
been diagnosed, the epilepsy 
standards apply. These cases will 
include all cases of single seizure 
where a primary cerebral cause 
is present and the liability to 
recurrence cannot be excluded. 
An exception may be made when 
seizures occur at the time of an 
acute head injury or intracranial 
surgery. 
When seizures occur at the 
time of intracranial venous 
thrombosis, 6 months is 
required, free from attacks, 
before resuming driving.
Driver must notify NDLS.
In all cases where a “liability to 
epileptic seizures” either primary or 
secondary has been diagnosed, the 
specific epilepsy standard for this 
group applies. The only exception 
is a seizure occurring immediately 
at the time of an acute head injury 
or intracranial surgery, and not 
thereafter and/or where no liability 
to seizure has been demonstrated. 
Following head injury or intracranial 
surgery, the risk of seizure must 
have fallen to no greater than 2% 
per annum before returning to 
Group 2 driving.
Driver must notify NDLS.
Withdrawal of antiepileptic 
medication and driving
(See Appendix to this chapter  
for full standards).
(See Appendix to this chapter  
for full standards).
Provoked seizures 
(Apart from alcohol or  
illicit drug misuse)
(See Appendix to this chapter  
for full standards).
(See Appendix to this chapter  
for full standards).
Non Epileptic seizure attacks Can be considered once 
attacks have been satisfactorily 
controlled and there are no 
relevant mental health issues.
Can be considered once attacks have 
been satisfactorily controlled and 
there are no relevant mental health 
issues.
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Neurological Disorders Group 1 - Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
1 . Reflex Vasovagal Syncope 
Definite provocational factors 
with associated prodromal 
symptoms and which are 
unlikely to occur whilst sitting or 
lying. Benign in nature.
No driving restrictions. No driving restrictions.
If recurrent, will need to 
check the “3 Ps” apply on 
each occasion (provocation/
prodrome/postural). 
(If not see Number 6 below).
NDLS need not be informed. NDLS need not be notified.
N.B. Cough Syncope see Chapter 9
2 . Solitary loss of consciousness/
loss of or altered awareness 
likely to be unexplained syncope 
but with a high probability of 
reflex vasovagal syncope .
These have no clinical evidence 
of structural heart disease and a 
normal ECG.
No driving restrictions.
NDLS need not be informed.
Can drive 3 months after the event if 
no further recurrence.
N.B. Cough Syncope see Chapter 9
See Appendix at end of this chapter for epilepsy standards.
Loss of consciousness/loss of or altered awareness
Excluding Cough Syncope (See Chapter 9)
 
A full history is imperative to include pre-morbid history, prodromal symptoms, period of time unconscious, degree of 
amnesia and confusion on recovery. A neurological cause, for example, epilepsy, subarachnoid haemorrhage, can often 
be identified by the history, examination and the appropriate referral made. The relevant Sláinte agus Tiomáint guidelines 
will then apply. In 80% of all cases there is a cardiovascular cause and again, these can also be determined by history, 
examination and ECG. Investigate and treat accordingly and use the relevant Sláinte agus Tiomáint guidelines.
The remaining cases can be classified under five categories in the following table:
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See Appendix at end of this chapter for epilepsy standards.
Neurological Disorders Group 1 - Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
3 . Solitary loss of consciousness/ 
loss of or altered awareness 
likely to be cardiovascular in 
origin (Excluding 1 or 2 directly 
preceding).
Factors indicating high risk: 
A. Abnormal ECG.
B. Clinical evidence of 
structural heart disease.
C. Syncope causing injury, 
occurring at the wheel or 
whilst sitting or lying.
D. More than one episode in 
previous 6 months.
Further investigations such 
as ambulatory ECG (48hrs), 
echocardiography and exercise 
testing may be indicated after 
consultant opinion has been 
sought.
**For Pacemakers see Chapter 3
No driving for 6 months if no 
cause identified.
Can drive 4 weeks after 
the event if the cause has 
been identified and treated 
satisfactorily.
Driver must notify NDLS.
No driving for 12 months if no cause 
identified.
Can drive 3 months after the event 
if the cause has been identified and 
treated satisfactorily.
Driver must notify NDLS.
4 . Solitary loss of consciousness/
loss of or altered awareness 
with seizure markers .
This category is for those 
where there is a strong clinical 
suspicion of a seizure but no 
definite evidence.
Factors to be considered:
• Without reliable prodromal 
symptoms.
• Unconsciousness for more 
than 5 minutes.
• Amnesia longer than 5 
minutes.
• Injury.
• Tongue biting.
• Incontinence.
• Remain conscious but with 
confused behavior.
• Headache post attack.
6 months off driving from the 
date of an episode of loss of 
consciousness/loss of or altered 
awareness. However, if a person 
has a previous history of epilepsy 
or a solitary seizure, 12 months’ 
freedom from any further 
episode of loss of consciousness 
with seizure markers must be 
attained.
If a person suffers recurrent 
episodes of loss of consciousness 
with seizure markers, 12 
months’ freedom from such 
episodes must be attained.
Driver must notify NDLS.
5 years off driving from the date 
of an episode if the licence holder 
has undergone assessment by an 
appropriate consultant and no 
relevant abnormality has been 
identified on investigation, for 
example EEG and brain scan, where 
indicated.
Driver must notify NDLS.
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Neurological Disorders Group 1 - Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
5 . Solitary loss of consciousness/
loss of or altered awareness 
with no clinical pointers .
This category will have had 
appropriate neurological 
and cardiac opinion and 
investigations but with no 
abnormality detected.
No driving for 6 months.
Driver must notify NDLS.
No driving for 1 year if no further 
recurrence.
Driver must notify NDLS.
6 . Two or more episodes of 
loss of consciousness/loss of 
or altered awareness without 
reliable prodromal symptoms .
No driving for 12 months or until 
the risk has been reduced to 
< 20% per annum.
Driver must notify NDLS.
No driving for 5 years 
or until the risk has been reduced to 
< 2% per annum. 
Driver must notify NDLS.
Primary/Central Hypersomnias
Including Narcoleptic syndromes
Cease driving on diagnosis.
Fit to drive when there has 
been a period of between 3 and 
6 months satisfactory control 
of symptoms with appropriate 
treatment. If not on appropriate 
treatment, driving may be 
allowed subject to a satisfactory 
objective assessment of 
maintained wakefulness. 
Driver must notify NDLS if 
driving cessation is going to be 6 
months or greater.
Cease driving on diagnosis. 
Fit to drive subject to consultant 
assessment and a satisfactory 
objective assessment of 
maintained wakefulness. 
Driver must notify NDLS if driving 
cessation is going to be 6 months or 
greater.
See Appendix at end of this chapter for epilepsy standards.
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See Appendix at end of this chapter for epilepsy standards.
Neurological Disorders Group 1 - Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Chronic Neurological Disorders
E.g. Multiple sclerosis, motor 
neurone disease, myopathy etc., 
which may affect vehicle control 
because of impairment of co-
ordination and muscle power.
See section: Drivers with 
disabilities, Chapter 10.
Providing medical assessment 
confirms that driving 
performance is not impaired, 
can drive. 
1 or 3 year licence may be 
advised. Should the driver 
require a restriction to certain 
controls, the law requires this to 
be specified on the licence. Due 
consideration should be given to 
functional status, rehabilitation, 
specialist on-road assessment 
and adaptations which may 
help to adapt to, or overcome, 
relevant cognitive and physical 
impairment.
Driver must notify NDLS.
May not drive if condition is 
progressive or disabling. If driving 
would not be impaired and 
condition stable, can be considered 
for licensing subject to satisfactory 
consultant assessment and annual 
review.
Driver must notify NDLS.
Parkinson’s disease and other 
forms of Parkinsonism 
Should not drive if condition or 
functional status is sufficiently 
impaired so as to impair driving 
safety and/or there is clinically 
significant variability in motor 
function. Due consideration 
should be given to medication 
review (with due attention 
to tendency to drowsiness/ 
sleepiness), rehabilitation, 
specialist on-road assessment 
and adaptations which may 
help to adapt to, or overcome, 
relevant cognitive and physical 
impairment. If driving safety not 
impaired, can continue driving 
subject to satisfactory reports. 
Fitness to drive is subject to 
regular review.
Driver must notify NDLS.
Should not drive if condition is 
disabling and/or there is clinically 
significant variability in motor 
function. If driving would not be 
impaired, can be considered for 
licensing subject to individual 
assessment by a consultant.
Licence may be issued subject to 
annual review.
Driver must notify NDLS.
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Group 2 Entitlement ODL
Liability to sudden attacks of 
unprovoked or
unprecipitated disabling 
dizziness or vestibular symptoms
Cease driving on diagnosis . 
Driving will be permitted 
when satisfactory control of 
symptoms achieved. If remains 
asymptomatic a 10 year licence 
or if over 60 a licence expiring 
at age 70, can be issued. After 
age 70 a one or 3 year licence, 
subject to medical report, can 
be issued.
Driver must notify NDLS.
Cease driving on diagnosis .  
Consider underlying diagnosis 
and if likely to cause recurrent 
attacks, must be symptom- free and 
completely controlled for 1 year 
from last attack before resuming.
Driver must notify NDLS.
See Appendix at end of this chapter for epilepsy standards.
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See Appendix at end of this chapter for epilepsy standards.
Neurological Disorders Group 1 - Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Stroke/TIA TIA
NO need to notify NDLS.
Must not drive for 4 weeks .
Stroke
Must not drive for 4 weeks . 
May resume driving after this 
period if the clinical recovery is 
satisfactory. There is no need 
to notify NDLS unless there is 
significant residual neurological 
deficit 4 weeks after the episode; 
of particular importance are 
visual field defects, cognitive 
defects including visual neglect 
and inattention and impaired 
limb function. Minor limb 
weakness alone will not require 
notification unless restriction 
to certain types of vehicle or 
vehicles with adapted controls 
is needed. Due consideration 
should be given to risk of 
reoccurrence, rehabilitation, 
specialist on-road assessment 
and adaptations which may 
help to adapt to, or overcome, 
relevant cognitive and physical 
impairment.
Seizures occurring at the time 
of a stroke/TIA or in the ensuing 
24 hours may be treated as 
provoked for licensing purposes 
in the absence of any previous 
seizure history or previous 
cerebral pathology. 
TIA
Must not drive for at least 3 months 
following a TIA. 
Stroke
Must not drive for at least 3 months 
following a stroke.
Further driving requires annual 
medical review:
May drive after at least 3 months 
and subject to at least annual review 
taking into account:
• the nature of the driving task 
(e.g. petrol tanker v light van).
• information provided by an 
appropriate consultant regarding 
the level of impairment of any 
of the following: visuospatial 
perception, insight, judgement, 
attention, reaction time, 
memory, sensation, muscle 
power, coordination, vision 
(including visual fields) and the 
likely impact on driving ability.
• the results of a practical driver 
assessment if required. 
• the risk of recurrence.
• if intra-cerebral haemorrhage, 
that the risk of seizure is 2% or 
less per annum, as judged by 
competent specialist. 
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Acute Encephalitic Illnesses 
Including Limbic Encephalitis 
associated with seizures .
1. If no seizure(s), may resume 
driving when clinical 
recovery is complete. (The 
Driver must notify NDLS only 
if there is significant residual 
disability).
2. If associated with seizures 
during acute febrile illness, 
no driving for 6 months from 
the date of seizure(s). Driver 
must notify NDLS.
3. If associated with any 
seizure(s) early or late during 
or after convalescence, will 
be required to meet current 
epilepsy standards.
1. As for Group 1 provided no 
residual disabling symptoms, 
and clinical recovery is complete 
as assessed by a neurologist. 
(The Driver must notify NDLS 
only if there is significant 
residual disability).
2. If associated with seizures 
during acute febrile illness  
must stop driving and Driver 
must notify NDLS.
(a) Encephalitis – there have been 
no further seizures for at 
least 12 months without use 
of antiepileptic medication 
assessment by neurologist 
required.
If associated with any seizure(s) 
early or late during or after 
convalescence, must stop driving, 
Driver must notify NDLS and meet 
current epilepsy standards before 
driving resumes.
See Appendix to this Chapter  
for full standards.
Transient Global Amnesia Provided epilepsy, any sequelae 
from head injury and other 
causes of altered awareness 
have been excluded, no 
restriction on driving. 
NDLS need not be notified. 
A single confirmed episode does not 
require cessation of driving. If two or 
more episodes occur, driving should 
cease and Driver must notify NDLS. 
Consultant assessment required to 
exclude all other causes of acute 
transient memory loss.
See Appendix at end of this chapter for epilepsy standards.
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See Appendix at end of this chapter for epilepsy standards.
Neurological Disorders Group 1 - Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Arachnoid Cysts
Asymptomatic and untreated .
No restriction. No restriction.
Craniotomy and/or  
Endoscopic Treatment .
6 months off driving. 
Driver must notify NDLS.
Can drive 2 years after treatment, 
provided that there is no debarring 
residual impairment likely to affect 
driving safety.
Driver must notify NDLS.
Colloid Cysts
Asymptomatic and untreated .
No restriction. No restriction unless prescribed 
prophylactic medication for seizures 
when there should be individual 
assessment.
Driver must notify NDLS.
Craniotomy and/or  
Endoscopic Treatment .
6 months off driving.
Driver must notify NDLS.
Can drive 2 years after treatment, 
provided that there is no debarring 
residual impairment likely to affect 
driving safety.
Driver must notify NDLS.
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Pituitary Tumour Provided no visual field defect.
If visual field loss:-
See section: Visual Disorders 
Chapter 7.
Provided no visual field defect 
If visual field loss:-
See section: Visual Disorders  
Chapter 7.
Craniotomy 6 months off driving.
Driver must notify NDLS.
2 years off driving.
Driver must notify NDLS.
Transphenoidal surgery/ 
other treatment 
(E.g. Drugs, Radiotherapy) or 
Untreated
Drive on recovery. Can drive when there is no debarring 
residual impairment likely to affect 
driving safety.
Benign Supratentorial Tumour
E.g. WHO Grade 1 Meningiomas 
Treatment by Craniotomy 6 months off driving when there 
is no debarring 
residual impairment likely to 
affect safe driving. 
Driver must notify NDLS.
Epilepsy standards apply if 
relevant history of seizure(s).
Not fit to drive. 
In the absence of any seizures, 
a short period licence can be 
considered 5 years after surgery, 
with evidence of complete removal. 
If tumour is associated with 
seizures, 10 years freedom from 
seizures without antiepileptic drugs 
following surgery and consultant 
assessment is required.
Driver must notify NDLS.
Treatment with  
Stereotactic Radiosurgery 
4 weeks off driving; thereafter 
can drive when there is no 
debarring residual impairment 
likely to affect driving safety. 
Driver must notify NDLS.
Epilepsy standards apply if 
relevant history of seizure(s).
3 years after the completion of the 
primary treatment of the tumour the 
driver can be considered fit to drive, 
provided that there is evidence 
on imaging of stability. If tumour 
association with seizure(s), 10 years’ 
freedom from seizures without 
antiepileptic drugs following surgery 
and consultant assessment is 
required.
Driver must notify NDLS.
See Appendix at end of this chapter for epilepsy standards.
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Treatment with  
Fractionated Radiotherapy
Can drive on completion of 
treatment, provided that 
there is no debarring residual 
impairment likely to affect safe 
driving. 
Epilepsy standards apply if 
relevant history of seizure(s).
3 years after the completion of the 
primary treatment of the tumour the 
driver can be considered fit to drive, 
provided that there is evidence 
on imaging of stability. If tumour 
association with seizure(s), 10 years’ 
freedom from seizures without 
antiepileptic drugs following surgery 
and consultant assessment is 
required.
Driver must notify NDLS.
WHO Grade II Meningiomas 
treated by Craniotomy  
and/or Radiosurgery and/or 
Radiotherapy
Requires 1 year off driving, 
dating from the completion of 
treatment; thereafter can drive 
when there is no debarring 
residual impairment likely to 
affect driving safety.
Driver must notify NDLS.
Epilepsy standards apply if 
relevant history of seizure(s). 
Not fit to drive. 
Driver must notify NDLS. 
In the absence of any seizures, 
return to driving can considered 5 
years after surgery, with evidence 
of complete removal. If tumour is 
associated with seizure(s), 10 years 
freedom from seizures without 
antiepileptic drugs following surgery 
is required. Consultant assessment 
may be required.
Asymptomatic, incidental 
meningiomas: Untreated
Continue driving. Requires cessation of driving until 
two scans 12 months apart showing 
no growth. If growth, consultant 
assessment with 1 year short period 
licence and review.
Driver must notify NDLS.
See Appendix at end of this chapter for epilepsy standards.
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Benign Infratentorial Tumours 
E.g. Meningioma with surgery 
by craniotomy with or without 
radiotherapy.
Drive on recovery. As for Group 1 provided that there 
is no debarring residual impairment 
likely to affect driving safety.
Acoustic Neuroma/Schwannoma Need not notify NDLS unless 
sudden and disabling vestibular 
symptoms.
Need not notify NDLS unless 
accompanied by disabling vestibular 
symptoms and/or the condition is 
bilateral.
Malignant Tumours (including 
metastatic deposits) 
and Gliomas
Supratentorial 
Gliomas Grades I and II 
1 year off driving, from time 
of completion of the primary 
treatment; thereafter can drive 
when there is no debarring 
residual impairment likely to 
affect driving safety. 
Driver must notify NDLS.
Not fit to drive. (Pineocytoma, Grade 
I, can be considered on an individual 
basis 2 years post primary treatment 
if satisfactory MRI). 
Driver must notify NDLS.
WHO Grade III Meningioma 2 years off driving from time 
of completion of primary 
treatment; thereafter can drive 
when there is no debarring 
residual impairment likely to 
affect driving safety.
Driver must notify NDLS.
Not fit to drive. (Pineocytoma, Grade 
I, can be considered on an individual 
basis 2 years post primary treatment 
if satisfactory MRI). 
Driver must notify NDLS.
Gliomas Grade III and IV and 
Metastatic Deposit(s) .
At least 2 years off driving from 
time of completion of primary 
treatment;thereafter can drive 
when there is no debarring 
residual impairment likely to 
affect driving safety.
Driver must notify NDLS.
Not fit to drive.
Driver must notify NDLS.
See Appendix at end of this chapter for epilepsy standards.
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Solitary Metastatic Deposit If totally excised, can be 
considered for recommending 1 
year licence after completion of 
primary treatment if free from 
recurrence and no evidence of 
secondary spread elsewhere in 
the body; thereafter can drive 
when there is no debarring 
residual impairment likely to 
affect driving safety.
Driver must notify NDLS.
Not fit to drive.
Driver must notify NDLS.
Infratentorial Tumours
Gliomas Grade I 
As for benign tumours: i.e. drive 
on recovery.
Individual assessment. 
Gliomas Grade II, III & IV As for Supratentorial tumour. Not fit to drive.
Driver must notify NDLS.
Medulloblastoma or Low Grade 
Ependymoma
If totally excised, can be 
considered for 1 year licence 
after primary treatment, if free 
from recurrence.
If entirely infratentorial, may be 
considered for driving when disease-
free for 5 years after treatment.
High Grade Ependymomas,  
Other Primary Malignant  
Brain Tumours and Primary CNS 
Lymphomas
Normally, a period of 2 years 
off driving is required following 
treatment.
Driver must notify NDLS.
Not fit to drive.
Driver must notify NDLS.
Metastatic deposits Can be considered for driving 
on a 1 year licence after 
completion of primary treatment 
if otherwise well.
Driver must notify NDLS.
May drive 5 years from the date of 
completion of the primary treatment 
if asymptomatic and subject to 
annual consultant review.
Driver must notify NDLS.
Malignant Intracranial Tumours 
in children who survive to adult 
life without recurrence
Normally, till 70 licence is 
issued/maintained.
Individual assessment: see above as 
for “Benign Supratentorial Tumour”.
When a low grade glioma is an incidental finding and asymptomatic, the case may be considered on an 
individual basis for Group 1.
See Appendix at end of this chapter for epilepsy standards.
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Traumatic brain injury Usually requires 6-12 months 
off driving depending on 
features such as seizures, post-
traumatic amnesia, dural tear, 
haematoma and contusions. 
There will need to have been 
a satisfactory clinical recovery 
and in particular no visual 
field defect, or cognitive or 
behavioural impairment likely 
to affect driving safety. Due 
consideration should be given to 
rehabilitation, specialist on-road 
assessment and adaptations 
which may help to adapt to, or 
overcome, relevant cognitive 
and physical impairment.
Driver must notify NDLS.
Not fit to drive if the person has had 
head injury producing significant 
impairment of any of the following: 
visuospatial perception, insight, 
judgement, attention, reaction time, 
memory, sensation, muscle power, 
coordination, vision (including visual 
fields).
May be able to return to driving when 
the risk of seizure has fallen to no 
greater than 2% per annum, and with 
no debarring residual impairment 
likely to affect driving safety.
Periodic review is not required if the 
condition is static.
Driver must notify NDLS.
See Appendix at end of this chapter for epilepsy standards.
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Spontaneous Acute Subdural 
Haematoma
(Treated by Craniotomy)
6 months off driving if no 
significant residual disability. 
If significant residual disability, 
due consideration should 
be given to rehabilitation, 
specialist on-road assessment 
and adaptations which may 
help to adapt to, or overcome, 
relevant cognitive and physical 
impairment. 
Driver must notify NDLS.
At least 6 months off driving, 
with an individual assessment by 
consultant as to fitness to return to 
driving.
Driver must notify NDLS.
Chronic Subdural
(Treated surgically)
Resume driving on recovery if 
no significant residual disability. 
If significant residual disability, 
due consideration should 
be given to rehabilitation, 
specialist on-road assessment 
and adaptations which may 
help to adapt to, overcome, 
relevant cognitive and physical 
impairment.
Driver must notify NDLS.
6 months –1 year off driving, with an 
individual assessment by consultant 
as to fitness to return to driving.
Driver must notify NDLS.
See Appendix at end of this chapter for epilepsy standards.
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Subarachnoid Haemorrhage 
1 . No cause found
Provided comprehensive 
cerebral angiography normal, 
may resume driving following 
recovery if no significant 
residual disability. If significant 
residual disability, due 
consideration should be given to 
rehabilitation, specialist on-road 
assessment and adaptations 
which may help to adapt to, or 
overcome, relevant cognitive 
and physical impairment.
Driver must notify NDLS.
Continued on next page
Provided comprehensive cerebral 
angiography normal, 6 months off 
driving and may regain licence if no 
debarring residual impairment likely 
to affect driving safety.
Driver must notify NDLS.
Continued on next page
See Appendix at end of this chapter for epilepsy standards.
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Modified Rankin Scale (mRS)
Group 1 Entitlement ODL car, 
motorcycle and tractor
Group 2 Entitlement ODL
Craniotomy Non 
Middle Cerebral 
Artery Aneurysm
Drive on clinical recovery mRS < 2 at 2 months 
12 months off 
driving.
mRS 2 or > at 2 
months 24 months 
off driving, there 
should be no residual 
impairment likely to 
affect driving.
Craniotomy Middle 
Cerebral Artery 
Aneurysm
Drive on clinical recovery mRS < 2 at 2 months 
24 months off 
driving.
mRS 2 or > at 2 
months. Refusal or 
Revocation. See* 
below.
Endovascular 
Treatment Non 
Middle Cerebral 
Artery Aneurysm
Drive on clinical recovery mRS < 2 at 2 months 
6 months off driving
mRS 2 or > at 2 
months 24 months 
off driving, there 
should be no residual 
impairment likely to 
affect driving.
Endovascular 
Treatment Middle 
Cerebral Artery 
Aneurysm
Drive on clinical recovery mRS < 2 at 2 months 
24 months off 
driving.
mRS 2 or > at 2 
months Refusal or 
Revocation. See* 
below.
* Consultant assessment required, seizure risk should be 2% per annum or less and there should be no residual 
impairment likely to affect driving.
Subarachnoid Haemorrhage 
2A . Intracranial Aneurysm
N .B . If any other procedure is undertaken e.g. V.P. shunt, craniotomy for a haematoma etc. then the standards for that 
procedure shall apply.
See Appendix at end of this chapter for epilepsy standards.
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Subarachnoid Haemorrhage 
2B . No Treatment 
i.e. Aneurysm responsible for 
SAH but no intervention. 
6 months off driving. Not fit to drive.
Subarachnoid Haemorrhage 
2C . Truly Incidental Findings of 
Intracranial Aneurysm (aneurysm 
has not been responsible for 
subarachnoid haemorrhage) 
No Treatment
Drive on clinical recovery. To be acceptable for licensing, 
anterior circulation aneurysms 
(excluding cavernous carotid) must 
be < 13mm in diameter. Posterior 
circulation aneurysms must be < 
7mm diameter.
Surgery Craniotomy Drive on clinical recovery. 1 year off driving. 
Endovascular Treatment Drive on clinical recovery. Cease driving until clinical recovery 
unless there are complications from 
the procedure as determined by 
treating consultant.
N.B. The above is independent of the 
standard for ruptured aneurysm in 
section 2A.
See Appendix at end of this chapter for epilepsy standards.
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Arteriovenous Malformation
N .B . If any other procedure is undertaken e.g. V.P. shunt, craniotomy for a haematoma etc. then the standards for 
that procedure shall apply. 
Arteriovenous Malformation Supratemtorial AVMS
Intracerebral Haemorrhage due to Supratemtorial AVM
A . Craniotomy 6 months off driving; can drive 
thereafter when there is no 
debarring residual impairment 
likely to affect driving. If 
significant residual disability, 
due consideration should 
be given to rehabilitation, 
specialist on-road assessment 
and adaptations which may 
help to adapt to, or overcome, 
relevant cognitive and physical 
impairment. 
Driver must notify NDLS.
Requires cessation of driving until 
lesion is completely removed or 
ablated and 10 years seizure-free 
from last definitive treatment. 
There must be no debarring residual 
impairment likely to affect driving.
Driver must notify NDLS.
B . Other treatment (embolisation 
or stereotactic radiotherapy)
4 weeks off driving; can drive 
thereafter when there is no 
debarring residual impairment 
likely to affect driving.
Requires cessation of driving until 
lesion is completely removed or 
ablated and 10 years seizure-free 
from last definitive treatment. 
There must be no debarring residual 
impairment likely to affect driving.
Driver must notify NDLS.
C . No treatment 4 weeks off driving; can drive 
thereafter when there is no 
debarring residual impairment 
likely to affect driving.
Not fit to drive .
Driver must notify NDLS.
See Appendix at end of this chapter for epilepsy standards.
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Incidental finding of a supratentorial AVM
(no history of intracranial bleed)
A . No treatment No restriction. Not fit to drive.
Driver must notify NDLS.
B . Surgical or other treatment See above: as for AVM with 
Intracranial Haemorrhage.
Not fit to drive until lesion is 
completely removed or ablated 
and 10 years seizure-free from last 
definitive treatment. There must be 
no debarring residual impairment 
likely to affect driving.
Driver must notify NDLS.
Infratentorial AVMs Intracranial haemorrhage due to AVM:
A . Treated by Craniotomy Can drive when there is no 
debarring residual impairment 
likely to affect driving.
Not fit to drive until confirmation 
of complete obliteration with no 
debarring residual impairment likely 
to affect driving.
Driver must notify NDLS.
B . Embolisation/Stereotactic 
Radiotherapy
Can drive when there is no 
debarring residual
impairment likely to affect 
driving.
Not fit to drive until confirmation 
of complete obliteration with no 
debarring residual impairment likely 
to affect driving.
Driver must notify NDLS.
C . No treatment Can drive when there is no 
debarring residual impairment 
likely to affect driving.
Not fit to drive.
Driver must notify NDLS.
See Appendix at end of this chapter for epilepsy standards.
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Incidental finding of an infratentorial AVM
A . No treatment No restriction. Not fit to drive . 
Driver must notify NDLS.
B . Surgical or other treatment Can drive when there is no 
debarring residual impairment 
likely to affect driving.
Not fit to drive until confirmation 
of complete obliteration with no 
debarring residual impairment likely 
to affect driving.
Driver must notify NDLS.
Dural AV Fistula Continued driving subject to 
individual assessment.
Driving may continue subject 
to individual assessment by 
appropriate consultant. 
Driver must notify NDLS.
Cavernous Malformation Supratentorial
A . Incidental, no surgical 
treatment
No restriction. No restriction subject to individual 
assessment by appropriate 
consultant.
B . Seizure, no surgical treatment Epilepsy standards apply if 
history of seizure(s).
Epilepsy standards apply if history of 
seizure(s).
C . Haemorrhage and/or focal 
neurological deficit, no surgical 
treatment
Can drive when there is no 
debarring residual impairment 
likely to affect driving. 
Epilepsy standards apply if 
history of seizure(s).
Not fit to drive .
Driver must notify NDLS.
See Appendix at end of this chapter for epilepsy standards.
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D . Treated by Surgical Excision
(Craniotomy)
Can drive when there is no 
debarring residual
impairment likely to affect 
driving. If significant residual 
disability, due consideration 
should be given to 
rehabilitation, specialist on-road 
assessment and adaptations 
which may help to adapt to, or 
overcome, relevant cognitive 
and physical impairment. 
Driver must notify NDLS. 
Epilepsy standards apply if 
history of seizure(s).
Not fit to drive until 10 years 
post-obliteration of the lesion and 
epilepsy standards apply.
Driver must notify NDLS.
E . Treated by radiosurgery
(I). Incidental No restriction. Not fit to drive .
Driver must notify NDLS.
(II). Symptomatic Can drive when there is no 
debarring residual impairment 
likely to affect driving. 
Epilepsy standards apply if 
history of seizure(s).
Not fit to drive .
Driver must notify NDLS.
See Appendix at end of this chapter for epilepsy standards.
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Infratentorial
A . Incidental No restriction. Can drive subject to specialist 
assessment by appropriate 
consultant. 
Driver must notify NDLS.
B . With focal Neurological 
Deficit or Haemorrhage whether 
treated surgically or not
Can drive when there is no 
debarring residual impairment 
likely to affect driving.
Epilepsy standards apply if 
history of seizure(s).
Can drive when there is no debarring 
residual impairment likely to affect 
driving.
Epilepsy standards apply if history  
of seizure(s). 
Driver must notify NDLS.
Neurological Disorders Group 1 - Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Intracerebral Abscess/ 
Subdural Empyema
One year off driving. 
Driver must notify NDLS.
Not fit to drive. Very high 
prospective risk of seizure(s). May 
consider licensing if 10 years seizure-
free from treatment.
Driver must notify NDLS.
Hydrocephalus If uncomplicated, can be 
recommended for continued 
driving.
Can be issued with a licence if 
uncomplicated and no associated 
neurological problems.
Intraventricular Shunt or 
Extraventricular Drain
Insertion or revision of upper 
end of ventricular shunt or extra-
ventricular drain
6 months off driving. Can be 
recommended for continued 
driving thereafter when there is 
no debarring residual impairment 
likely to affect driving safety.
Driver must notify NDLS.
Minimum 6 months off and then 
licensing shall be dependent upon 
the individual assessment of the 
underlying condition.
Driver must notify NDLS.
See Appendix at end of this chapter for epilepsy standards.
N.B. Multiple Cavernoma: no firm evidence of  morbidity. Size is not an issue
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Neurological Disorders Group 1 - Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Neuroendoscopic procedures 
E.g. IIIrd ventriculostomy
6 months off driving. Can be 
recommended for continued 
driving thereafter when 
there is no debarring residual 
impairment likely to affect safe 
driving.
Driver must notify NDLS.
Minimum 6 months off and then 
licensing shall be dependent upon 
the individual assessment of the 
underlying condition.
Driver must notify NDLS.
Intracranial Pressure  
Monitoring Device
Inserted by Burr hole surgery
The prospective risk from the 
underlying condition must be 
considered.
The prospective risk from the 
underlying condition must be 
considered.
Implanted Electrodes
Deep brain stimulation for 
movement disorder or pain 
If no complications from surgery 
and seizure, can drive when 
there is no debarring residual 
impairment likely to affect 
driving safety.
Driver must notify NDLS.
If no complications from surgery, 
seizure free and underlying condition 
non-progressive, can drive when there 
is no debarring residual impairment 
likely to affect driving safety.
Driver must notify NDLS.
Implanted Motor Cortex 
stimulator for pain relief
If aetiology of pain is non-
cerebral e.g. trigeminal 
neuralgia, 6 months off driving. 
If the aetiology is cerebral e.g. 
stroke, 12 months off driving. 
Can then drive when there is no 
debarring residual impairment 
likely to affect driving safety.
Not fit to drive.
Driver must notify NDLS.
See Appendix at end of this chapter for epilepsy standards.
Sláinte agus Tiomáint  |  Medical Fitness To Drive Guidelines  |  (Group 1 and Group 2 Drivers)    43 
Údarás Um Shábháilteacht Ar Bhóithre
Road Safety Authority
Appendix — Chapter 2
Epilepsy standards for Group 1 and 2
Group 1
This means that:
1. A person who has suffered an epileptic attack whilst awake must refrain from driving for at least one year from the 
date of the attack: driving cannot resume until the driver has had no further seizures while awake for a 12-month 
period.
2. A person who has experienced seizures exclusively while asleep may be considered for a one year licence despite 
continuing seizures only during sleep, and subject to at least annual review, taking into account information provided 
by the treating doctor (with appropriate expertise and due consultation as required) as to whether the following 
criteria are met:
• There have been no previous seizures while awake; and 
• The first sleep-only seizure was at least 12 months ago; and 
• The person follows medical advice, including adherence to medication if prescribed. 
 or
• There have been previous seizures while awake but not in the preceding one year; and 
• Sleep-only seizures have been occurring for at least one year; and 
• The person follows medical advice, including adherence to medication if prescribed. 
and in both cases
3. I. So far as practicable, the person complies with advised treatment and check-ups for epilepsy,
 AND
 II. The driving of a vehicle by such a person should not be likely to cause danger to the public. 
A specific exception to these are seizures a judged by the treating consultant neurologist as not impairing consciousness 
or driving ability at any time. An annual licence may be granted by the National Driver Licence Service (NDLS) subject to 
at least annual review, taking into account information provided by the treating consultant as to whether the following 
criteria are met:
• Seizures not impairing consciousness or driving ability at any time have been present for at least one year; and 
• There have been no seizures of other type for at least one year; and 
• The person follows medical advice, including adherence to medication if prescribed. 
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Group 2
This means that:
During the period of 10 years immediately preceding the date when the licence is granted the applicant/licence holder 
should:
1) be free from any epileptic attack
 AND
2) have not taken medication to treat epilepsy
 AND
3) not otherwise be a source of danger whilst driving.
In addition, someone with a structural intracranial lesion who has an increased risk of seizures will not be able to drive 
vehicles of this group until the risk of a seizure has fallen to no greater than 2% per annum, which permits compliance 
with the standards.
Guidance for clinicians advising patients to cease driving in the case of  
break-through seizures in those with established epilepsy for Group 1 Drivers:
In the event of a seizure, the driver must be advised not to drive unless they are able to meet the conditions of the asleep 
concessions. The patient must be advised to notify the NDLS. In exceptional cases (e.g. seizure secondary to prescribing 
error), a consultant may advise a return after a shorter period.
Guidance for withdrawal of antiepileptic medication being withdrawn on specific  
medical advice for Group 1 Drivers: 
(N .B . This advice only relates to treatment for epilepsy) 
From a medico-legal point of view, the risk of further epileptic seizures occurring during this therapeutic procedure should 
be noted. If an epileptic seizure does occur, the patient will need to satisfy driving licence standards before resuming 
driving and will need to be counselled accordingly. The current epilepsy standards require a period of at least one year 
free of any manifestation of epileptic seizure or attacks whilst awake from the date of the last attack; special consideration 
is given where attacks have occurred only whilst asleep.
It is clearly recognised that withdrawal of antiepileptic medication is associated with a risk of seizure recurrence. A number 
of studies have shown this, including the randomised study of antiepilepsy drug withdrawal in patients in remission, 
conducted by the UK Medical Research Council Anti-epileptic Drug Withdrawal Study Group in the UK17. This study shows 
a 30% risk of seizure in the first year of withdrawal ofmedication compared with those who continued on treatment.
Patients undergoing withdrawal of antiepilepsy medications should be warned of the risk they run, both of needing to 
cease driving and also of having a seizure which could result in a road traffic accident. Patients should be advised not 
to drive from commencement of the period of withdrawal and thereafter for a period of 6 months after cessation of 
treatment. A person remains as much at risk of seizure associated with drug withdrawal during the period of withdrawal 
as in the 6 months after withdrawal. 
17. Bonnett LJ, Shukralla A, Tudur-Smith C, Williamson PR, Marson AG. Seizure recurrence after antiepileptic drug withdrawal and the implications for driving: 
further results from the MRC Antiepileptic Drug Withdrawal Study and a systematic review. J Neurol Neurosurg Psychiatry. 2011 Dec;82(12):1328-33.
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This advice may not be appropriate in every case. One specific example is withdrawal of antiepileptic medication when there 
is a well-established history of seizures only while asleep. In such cases, any restriction in driving is best determined by the 
consultant concerned, after considering the history. It is up to the driver to comply with such advice.
It is important to remember that the epilepsy standards are still relevant even if epileptic seizures occur after medication 
is omitted, for example on admission to hospital for any condition . 
Provoked seizures
Provoked or acute symptomatic seizures may be dealt with on an individual basis if there is no previous seizure history. 
Seizures associated with alcohol or drug misuse, sleep deprivation or a structural abnormality is not considered provoked 
for licensing purposes . Similarly, reports of seizures as a side-effect of prescribed medication do not automatically imply 
that such events should be considered as provoked . For seizure(s) with alcohol or illicit drugs, please see Chapter 6 in 
these Guidelines.
Doctors may wish to advise patients that the period of time likely to be recommended off driving will be influenced inter 
alia by:
A. Whether it is clear that the seizure had been provoked by a stimulus which does not convey any risk of recurrence 
and does not represent an unmasking of an underlying liability; 
 AND
B. Whether the stimulus had been successfully/appropriately treated or is unlikely to occur at the wheel.
In the absence of any previous seizure history or previous cerebral pathology, the following seizures may also be treated 
as provoked: 
• Eclamptic seizures.
• Convulsive syncope. 
• Seizure in first week following a head injury (see head injury section) at the time of a Stroke/TIA or within the ensuing 
24 hours.
• During intracranial surgery or in the ensuing 24 hours.
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Chapter 3
Cardiovascular disorders18
A licence holder or applicant must meet the standards for cardiovascular disorders outlined below, and if there is reason 
to doubt that these are met, the applicant or licence holder should undergo a more detailed examination by a consultant 
cardiologist — see Appendix to this chapter. 
Group 2 standards are minimum standards and do not preclude employers setting higher standards in terms of the 
demands of the driving tasks encountered in the course of employment. 
Cardiovascular Disorders Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Angina Driving must cease when 
symptoms occur at rest, with 
emotion, or at the wheel .
Driving may recommence when 
satisfactory symptom control is 
achieved. 
NDLS need not be notified.
Refusal or revocation with 
continuing symptoms (treated  
and/or untreated) .
Driving may recommence  
thereafter provided:
• Free from angina for at least  
4 weeks.
• The exercise or other functional 
test requirements can be met.
• There is no other disqualifying 
condition.
Driver must notify NDLS.
See appendix at end of this chapter
18. Helpful recent reviews include: Sorajja D, Shen WK. Driving guidelines and restrictions in patients with ahistory of cardiac arrhythmias, syncope,or implantable 
devices. Curr Treat Options Cardiovasc Med. 2010 Oct;12(5):443-56.
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Cardiovascular Disorders Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Acute Coronary Syndromes  
(ACS) defined as:
1. Unstable angina (symptoms at 
rest with ECG changes).
2. Non STEMI with at least two 
of the following criteria:
• Symptoms at rest
• Raised serum Troponin
• ECG changes
3. STEMI symptoms with ST 
elevation on ECG.
If successfully treated by 
coronary angioplasty, driving 
may recommence after 1 week 
provided:
• No other URGENT 
revascularisation is planned. 
(URGENT refers to within 4 
weeks from acute event).
• Left Ventricular Ejection 
Fraction (LVEF) is at least 
35% prior to hospital 
discharge.
• There is no other 
disqualifying condition.  
If not successfully treated by 
coronary angioplasty, driving 
may recommence after 4 
weeks provided:
• There is no other 
disqualifying condition.
All Acute Coronary Syndromes 
disqualify the licence holder from 
driving for at least 4 weeks.
Driving may recommence thereafter 
provided:
• The exercise or other functional 
test requirements can be met.
• There is no other disqualifying 
condition.
Driver must notify NDLS.
See appendix at end of this chapter
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Cardiovascular Disorders Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Percutaneous Coronary 
Intervention
(Angioplasty ± stent)
Elective
Driving must cease for at least 
2 days .
Driving may recommence 
thereafter provided there is no 
other disqualifying condition. 
NDLS need not be notified.
Driving must cease for at least  
4 weeks .
Driving may recommence thereafter 
provided:
• The exercise or other functional 
test requirements can be met.
• There is no other disqualifying 
condition.
Driver must notify NDLS.
Cardiac Surgery CABG including 
valve or replacement or repair
Driving must cease for at least 4 
weeks .
Driving may recommence 
thereafter provided there is no 
other disqualifying condition. 
NDLS need not be notified.
Disqualifies from driving for at least 
3 months .
Driving may recommence thereafter 
provided:
• There is no evidence of 
significant impairment of  
left ventricular function i.e.  
LVEF is ≥ 35%.
• The exercise or other functional 
test requirements can be met 
3 months or more post operatively.
• There is no other disqualifying 
condition.
Driver must notify NDLS.
See appendix at end of this chapter
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Cardiovascular Disorders Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Arrhythmia 
Sinoatrial disease
Significant atrio-ventricular 
conduction defect
Atrial flutter/fibrillation
Narrow or broad complex 
tachycardia
(See also following Sections 
- Pacemakers are considered 
separately). N .B . Transient 
Arrhythmias occurring during 
acute coronary syndromes do 
not require assessment under 
this section.
Driving must cease if the 
arrhythmia has caused or is 
likely to cause incapacity.
Driving may be permitted when 
underlying cause has been 
identified and controlled for at 
least 4 weeks.
NDLS need not be notified unless 
there are distracting/disabling 
symptoms.
Not fit to drive if the arrhythmia 
has caused or is likely to cause 
incapacity .
Driving may be permitted when:
• The arrhythmia is controlled for 
at least 3 months.
• The LVEF is ≥ 35%. 
• There is no other disqualifying 
condition.
NDLS need not be notified unless 
there are distracting/disabling 
symptoms.
Successful Catheter Ablation Driving must cease for at  
least 2 days .
Driving may be permitted 
thereafter provided there is no 
other disqualifying condition.
NDLS need not be notified.
Following successful catheter 
ablation for an arrhythmia that has 
caused or would likely have caused 
incapacity, driving should cease for 
6 weeks. Driving may recommence 
thereafter provided there is no other 
disqualifying condition.
When the arrhythmia has not 
caused nor would likely have caused 
incapacity, driving may recommence 
after 1 week provided there is no 
other disqualifying condition.
Pacemaker Implant
Includes box change
Driving must cease for at least 
1 week .
Driving may be permitted 
thereafter provided there is no 
other disqualifying condition.
Disqualifies from driving for  
4 weeks .
Driving may be permitted thereafter 
provided there is no other 
disqualifying condition.
See appendix at end of this chapter
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Cardiovascular Disorders Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Unpaced Congenital Complete 
Heart Block
May drive if asymptomatic . Not fit to drive whether 
symptomatic or asymptomatic.
Implantable Cardioverter 
Defibrillator (ICD)
Implanted for ventricular 
arrhythmia associated with 
incapacity
Patients with ICDs implanted 
for sustained ventricular 
arrhythmias should not drive for:
1. A period of 6 months after 
the first implant.
2. A further 6 months after 
any shock therapy and/or 
symptomatic antitachycardia 
pacing (see 3A below). 
3A. A period of 2 years if any 
therapy following device 
implantation has been 
accompanied by incapacity 
(whether caused by the 
device or arrhythmia), 
except as in 3B and 3C.
3B. If therapy was delivered due 
to an inappropriate cause, 
i.e. a trial fibrillation or 
programming issues, then 
fit to drive 4 weeks after 
this has been completely 
controlled to the satisfaction 
of the cardiologist.
NDLS need not be notified.
Continued on next page
Not fit to drive .
Driver must notify NDLS.
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Cardiovascular Disorders Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Implantable Cardioverter 
Defibrillator (ICD)
Implanted for ventricular 
arrhythmia associated with 
incapacity
Continued from previous page
3C. If the incapacitating shock 
was appropriate (i.e. for 
sustained VT or VF) and 
steps have been taken 
to prevent recurrence, 
(e.g., introduction of anti-
arrhythmic drugs or ablation 
procedure) fit to drive after 
6 months in the absence of 
further symptomatic therapy . 
For 2 and 3A/3C, if the patient 
has been re-licensed prior to the 
event, Driver must notify NDLS.
4. A period of 4 weeks off 
driving must occur following 
any revision of the electrodes 
or alteration of anti-
arrhythmic drug treatment.
5. A period of 1 week off 
driving is required after a 
defibrillator box change.
Return to driving requires that:
1. The device is subject to 
regular review with 
interrogation.
2. There is no other disqualifying 
condition.
See appendix at end of this chapter
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Cardiovascular Disorders Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Implantable Cardioverter 
Defibrillator (ICD)
Implanted for sustained 
ventricular arrhythmia which did 
not cause incapacity
If the patient presents with a 
non-disqualifying cardiac event, 
i.e. haemodynamically stable 
non-incapacitating sustained 
ventricular tachycardia, the 
patient can drive 4 weeks after 
ICD implantation providing all 
of the following conditions are 
met:
• LVEF is ≥ 35%.
• No fast VT induced on 
electrophysiological study 
(RR < 250 msec).
• Any induced VT could be pace-
terminated by the ICD twice, 
without acceleration, during 
the post implantation study.
NDLS need not be notified.
Should the ICD subsequently 
deliver ATP and/or shock therapy 
(except during normal clinical 
testing) then the licensing criteria 
on the previous page applies and 
Driver must notify NDLS.
Not fit to drive .
Driver must notify NDLS.
See appendix at end of this chapter
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Cardiovascular Disorders Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Prophylactic ICD Implant Asymptomatic individuals with 
high risk of significant arrhythmia. 
Driving should cease for 4 weeks. 
NDLS need not be notified.
Should the ICD subsequently 
deliver ATP and/or shock 
therapy (except during normal 
clinical testing) then the 
licensing criteria on previous 
page for ICD applies and  
Driver must notify NDLS.
Not fit to drive .
Driver must notify NDLS.
Ascending/Descending Thoracic 
and Abdominal Aortic Aneurysm
Driver must notify NDLS of any 
aneurysm of 6cm in diameter, 
despite treatment. Licensing  
will be permitted subject to 
annual review. 
Driving may continue after 
satisfactory medical (blood 
pressure control) or surgical 
treatment, without evidence 
of further enlargement. There 
should be no other disqualifying 
condition. An aortic diameter of 
6.5cm or more not fit to drive.
Not fit to drive if the aortic diameter 
is > 5 .5cm. Driving may continue 
after satisfactory medical or 
surgical treatment, unless other 
disqualifying condition.
N .B . The exercise or other functional 
test requirements will apply to 
abdominal aortic aneurysm .
Driver must notify NDLS if aortic 
diameter is > 5.5cm.
See appendix at end of this chapter
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Cardiovascular Disorders Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Chronic Aortic Dissection Driving may continue after 
satisfactory medical (blood 
pressure control) or surgical 
treatment, unless other 
disqualifying condition. 
NDLS need not be notified.
Driving may be permitted when ALL 
of the following criteria can be met:
• The maximum transverse 
diameter of the aorta, including 
false lumen/thrombosed 
segment, does not exceed 
5.5cm.
• There is complete thrombosis of 
the false lumen.
• The BP is well controlled*.
* NOTE “well controlled” refers to 
clinical, standard.
Hypertension Driving may continue unless 
treatment causes unacceptable 
side effects.
NDLS need not be notified.
Not fit to drive if resting BP 
consistently 180 mm Hg systolic  
or more and/or 100 mm Hg  
diastolic or more .
Driving may be permitted when 
controlled provided that treatment 
does not cause side effects which 
may interfere with driving.
See appendix at end of this chapter
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Cardiovascular Disorders Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Hypertrophic 
Cardiomyopathy (H .C .M .)
(See also arrhythmia, pacemaker 
and ICD sections)
Driving may continue provided 
no other disqualifying condition.
NDLS need not be notified.
Not fit to drive if symptomatic.
Driving may only be permitted 
when at least three of the following 
criteria are met:
• There is no family history in a 
first degree relative of sudden 
premature death from presumed 
HCM.
• The cardiologist can confirm that 
the HCM is not anatomically 
severe. The maximum wall 
thickness does not exceed 3cm.
• There is no serious abnormality 
of heart rhythm demonstrated; 
e.g. ventricular tachy-arrhythmia 
excluding isolated ventricular 
pre excitation beats.
• There is at least a 25mm Hg 
increase in systolic blood 
pressure during exercise testing 
- (exercise testing to be repeated 
every 3 years).
See Appendix to this Chapter  
for full details.
Driver must notify NDLS.
Dilated Cardiomyopathy
(See also arrhythmia, 
pacemaker, I.C.D. and heart 
failure sections etc.)
Driving may continue provided 
no other disqualifying condition.
NDLS need not be notified.
Not fit to drive if symptomatic .
Driving may be permitted provided 
that there is no other disqualifying 
condition. NDLS need not be 
notified.
See appendix at end of this chapter
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Cardiovascular Disorders Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Heart Failure Driving may continue provided 
there are no symptoms that may 
distract the driver’s attention.
NDLS need not be notified.
Disqualifies from driving  
if symptomatic .
Driving may be permitted provided:
• The LVEF is ≥ 35%. 
• There is no other disqualifying 
condition.
Exercise or other functional testing 
may be required depending on the 
likely cause for the heart failure.
Cardiac Resynchronisation 
Therapy (CRT)
CRT-P
Driving must cease for at least 1 
week following implantation .
Driving may continue provided 
there are no symptoms relevant 
to driving.
There is no other disqualifying 
condition.
Disqualifies from driving  
for 4 weeks . 
Following Implantation .
Driving may be permitted provided:
• The heart failure requirements 
are met.
• There is no other disqualifying 
condition.
CRT-D Driving may be permitted 
provided the ICD requirements 
are met. There is no other 
disqualifying condition.
Not fit to Drive .
Driver must notify NDLS.
See appendix at end of this chapter
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Cardiovascular Disorders Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Congenital Heart Disease Driving may continue provided 
there is no other disqualifying 
condition.
Following a first licence 
application or identification of 
such a condition, consultant 
assessment may be required 
before a licence is (re)issued. 
Certain conditions will require 
licence review every 1, 3 years, 
in this instance Driver must 
notify NDLS.
Disqualifies from driving when 
complex or severe disorder(s)  
is (are) present .
Following a first licence application 
or identification of such a condition, 
consultant cardiologist assessment 
may be required before a licence is 
(re)issued. Those with minor disease 
and others who have had successful 
repair of defects or relief of valvular 
problems, fistulae etc. may be 
licensed provided there is no other 
disqualifying condition.
Certain conditions will require 
licence review every 1, 3 years, in 
this instance Driver must notify 
NDLS.
Syncope 
N .B . Cough Syncope see Chapter 
9
See section entitled “Loss of 
Consciousness” Chapter 2.
See section entitled “Loss of 
Consciousness” Chapter 2.
ECG Abnormality 
Suspected myocardial infarction
Driving may continue unless 
other disqualifying condition. 
NDLS need not be notified.
Driving may be permitted provided:
• There is no other disqualifying 
condition.
• The exercise or other functional 
test requirements can be met.
See appendix at end of this chapter
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Appendix — Chapter 3
Group 1 and 2 entitlements
Medication
If drug treatment for any cardiovascular condition is required, any patient experiencing an adverse effect which is likely 
to affect driver performance is not fit to drive. 
 
Group 2 entitlements only 
LICENCE DURATION 
An applicant or driver who has, after cardiac assessment, (usually for ischaemic or untreated heart valve disease) been 
permitted to hold either a Group 2 licence will usually be issued with a short term licence (maximum duration 3 years) 
renewable on receipt of satisfactory D501 Medical Report.
Exercise testing
Exercise evaluation shall be performed on a treadmill. Drivers should be able to achieve 90% of age predicted heart rate of 
standard Bruce protocol or equivalent safely, without antianginal* medication for 48 hours and should remain free from 
signs of cardiovascular dysfunction, viz. angina pectoris, syncope, hypotension, sustained ventricular tachycardia, and/
or electrocardiographic ST segment shift which accredited medical opinion interprets as being indicative of myocardial 
ischaemia (usually > 2mm horizontal or down-sloping) during exercise or the recovery period. In the presence of established 
coronary heart disease, exercise evaluation shall be required at regular intervals not to exceed 3 years.
* Antianginal medication refers to the use of nitrates, beta-blockers, calcium channel blockers, nicorandil, ivabradine and 
ranolazine prescribed for antianginal purposes or for other reasons e .g . cardio-protection .
N .B . When any of the above drugs are being prescribed purely for the control of hypertension or an arrhythmiathen 
discontinuation prior to exercise testing is not required .
Should atrial fibrillation develop de novo during exercise testing, provided the individual meets all the NDLS exercise 
tolerance test criteria, the individual will be required to undergo an echocardiogram and meet the licensing criteria, just 
as any individual with a pre-existing atrial fibrillation.
Chest pain of uncertain cause
Exercise testing should be carried out as above. Those with a locomotor disability who cannot comply will require either 
a gated myocardial perfusion scan, stress echo study and/or specialised cardiological opinion.
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Stress Myocardial Perfusion Scan/Stress Echocardiography
The licensing standard requires that:
1. The LVEF is ≥ 35% 
2A) No more than 10% of the myocardium is affected by reversible ischaemic change on myocardial perfusion imaging.
 or
2B) No more than one segment is affected by reversible ischaemic change on stress echocardiography.
N .B . Full details of NDLS protocol requirements for such tests can be obtained on request .
Coronary Angiography
The functional implication of coronary heart disease is considered to be more predictive for licensing purposes than the 
anatomical findings. For this reason the exercise tolerance test and where necessary, myocardial perfusion imaging or 
stress echocardiography are the investigations of relevance for licensing purposes and it is the normal requirement that 
the standard of one or other of these must be met. Angiography is therefore not commissioned for (re-) licensing purposes. 
When there remains conflict between the outcome of a functional test and the results of recent angiography, such cases 
can be considered on an individual basis. However, (re-) licensing will not normally be considered unless the coronary 
arteries are unobstructed or the stenosis is not flow limiting and the LVEF is ≥ 35%. 
‘Predictive’ refers to the risk of an infarct within 1 year. Grafts are considered as ‘Coronary Arteries’.
ETT and Hypertrophic Cardiomyopathy
For the purpose of assessment of hypertrophic cardiomyopathy (HCM) cases, an exercise test falling short of exercise 
target above would be acceptable provided:
1. 90% of age-predicted heart rate.
2. There is no obvious cardiac cause for stopping the test prematurely. 
3 There is at least a 25mm Hg rise in systolic blood pressure during exercise testing.
4 Meets all other requirements as mentioned in HCM section.
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Diabetes Mellitus Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Insulin-Treated 
See Appendix to this chapter for 
advice to drivers.
• Has appropriate awareness 
of hypoglycaemia at 
appropriate glucose level. 
• Must not have had more 
than one episode of severe 
hypoglycaemia requiring the 
assistance of another person 
in the preceding twelve 
months.
• There must be appropriate 
blood glucose monitoring.
• Must not be regarded as a 
likely source of danger to the 
public while driving.
• The visual standards for 
acuity and visual field must 
be met.
Must not have impaired 
awareness of hypoglycaemia  
is defined as, ‘an inability 
to detect the onset of 
hypoglycaemia because of 
a total absence of warning 
symptoms’. 
If meets the medical standard 
a 1 or 3 year licence may be 
issued. 
Driver must notify NDLS.
May apply for any Group 2 licence. 
Must satisfy the following criteria:
• No episode of hypoglycaemia 
requiring the assistance of 
another person has occurred in 
the preceding 12 months.
• Has appropriate awareness of 
hypoglycaemia at appropriate 
glucose level. 
Impaired awareness of 
hypoglycaemia is defined as, ‘an 
inability to detect the onset of 
hypoglycaemia because of a total 
absence of warning symptoms’. 
• Regularly monitors blood 
glucose at least twice daily and 
at times relevant to driving 
using a glucose meter with a 
memory function to measure 
and record blood glucose levels. 
At the annual examination by 
a consultant endocrinologist, 
3 months of blood glucose 
readings must be available. 
• Must demonstrate an 
understanding of the risks of 
hypoglycaemia.
• There are no other debarring 
complications of diabetes such 
as a visual field defect.
If meets the medical standards a 
1 year licence may be issued. The 
treating endocrinologist is not obliged 
to provide a medical report on fitness 
to drive: in this case, the patient 
should be advised to seek a separate 
consultant endocrinologist for a 
medical report on fitness to drive.
Driver must notify NDLS.
Chapter 4
Diabetes Mellitus19
Failure to meet these standards or the presence of any progressive neurological disorder requires the applicant or licence 
holder to inform the NDLS unless stated otherwise in the text. Group 2 standards are minimum standards and do not preclude 
employers setting higher standards in terms of the demands of the driving tasks encountered in the course of employment.
See appendix at end of this chapter
19. Helpful recent reviews include: American Diabetes Association, Lorber D, Anderson J, Arent S, Cox DJ, Frier BM, Greene MA, Griffin J Jr, Gross G, Hathaway K, 
Hirsch I, Kohrman DB, Marrero DG, Songer TJ, Yatvin AL. Diabetes and driving. Diabetes Care. 2014 Jan;37 Suppl 1:S97-103.
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Diabetes Mellitus Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Temporary Insulin Treatment 
E.g. Post-Myocardial Infarction, 
participants in Oral/Inhaled 
Insulin Trials.
Provided they are under medical 
supervision, has appropriate 
awareness of hypoglycaemia at 
appropriate glucose level and 
have not been advised by their 
doctor that they are at risk of 
disabling hypoglycaemia, need 
not notify NDLS. If experiencing 
disabling hypoglycaemia, Driver 
must notify NDLS. 
Notify NDLS if treatment 
continues for more than 3 
months or for more than 3 
months after delivery for 
gestational diabetes.
May apply for any Group 2 licence. 
Must satisfy the following criteria 
• No episode of hypoglycaemia 
requiring the assistance of 
another person has occurred in 
the preceding 12 months.
• Has appropriate awareness of 
hypoglycaemia at appropriate 
glucose level.
Impaired awareness of 
hypoglycaemia is defined as, ‘an 
inability to detect the onset of 
hypoglycaemia because of a total 
absence of warning symptoms’. 
• Regularly monitors blood 
glucose at least twice daily and 
at times relevant to driving 
using a glucose meter with a 
memory function to measure 
and record blood glucose levels. 
At the annual examination by 
a consultant endocrinologist, 
3 months of blood glucose 
readings must be available. 
• Must demonstrate an 
understanding of the risks of 
hypoglycaemia.
• There are no other debarring 
complications of diabetes such 
as a visual field defect.
If meets the medical standards a 
1 year licence may be issued. The 
treating endocrinologist is not obliged 
to provide a medical report on fitness 
to drive: in this case, the patient 
should be advised to seek a separate 
consultant endocrinologist for a 
medical report on fitness to drive. 
Driver must notify NDLS.
See appendix at end of this chapter
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Diabetes Mellitus Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Managed by tablets which 
carry a risk of Inducing 
Hypoglycaemia . This includes 
Sulphonylureas and Glinides .
See Appendix to this chapter for 
advice to drivers . 
Must not have had more than 
one episode of hypoglycaemia 
requiring the assistance of 
another person within the 
preceding 12 months. It may be 
appropriate to monitor blood 
glucose regularly and driver 
should monitor blood glucose 
at times relevant to driving 
to enable the detection of 
hypoglycaemia. Has appropriate 
awareness of hypoglycaemia at 
appropriate glucose level. Must 
be under regular medical review. 
If however there has been a 
hypoglycaemic event in the 
preceding 12 months, Driver 
must notify NDLS.
Must satisfy the following criteria:
• No episode of hypoglycaemia 
requiring the assistance of 
another person has occurred in 
the preceding 12 months.
• Has appropriate awareness of 
hypoglycaemia at appropriate 
glucose level.
• Must show adequate control 
of condition by regularly 
monitoring blood glucose at 
least twice daily and at times 
relevant to driving.
• Must demonstrate an 
understanding of the risks of 
hypoglycaemia.
• There are no other debarring 
complications of diabetes such 
as a visual field defect.
If meets the medical standards a 
1 year licence may be issued. The 
treating endocrinologist is not 
obliged to provide a medical report 
on fitness to drive: in this case, the 
patient should be advised to seek a 
separate consultant endocrinologist 
for a medical report on fitness to 
drive.
Driver must notify NDLS.
Providing your diabetes is 
managed only by:
• tablets other than those 
mentioned above 
or by 
• non-insulin injectable 
medication
See Appendix to this chapter for 
advice to drivers . 
Need not notify NDLS unless 
develop associated conditions 
which are relevant to driving. 
E.g. Diabetic eye problems 
affecting visual acuity or visual 
field or if insulin required.
Need not notify the NDLS unless 
they develop relevant disabilities 
e.g. diabetic eye problems affecting 
visual acuity or visual fields, in 
which case not fit to drive or or 
short period licence.
Drivers are advised to monitor their 
blood glucose regularly and at times 
relevant to driving. They must be 
under regular medical review.
See appendix at end of this chapter
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Diabetes Mellitus Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Managed by diet alone Need not notify NDLS unless 
development of associated 
conditions which are relevant 
to driving e.g. diabetic eye 
problems affecting visual acuity 
or visual field or if insulin 
required.
Need not notify NDLS unless 
development of relevant disabilities 
e.g. diabetic eye problems affecting 
visual acuity or visual field or if 
insulin required.
Impaired awareness of 
Hypoglycaemia 
If confirmed, driving must 
stop. Fit to drive provided 
reports show awareness of 
hypoglycaemia has been 
regained, confirmed by 
consultant/GP report.
Not fit to drive . 
Driver must notify NDLS.
Eyesight Complications (affecting 
visual acuity or fields)
See section: Visual Disorders 
Chapter 7.
See previous page for insulin  
treated and See section:  
Visual Disorders Chapter 7
Renal Disorders See section: Renal Disorders 
Chapter 8.
See section: Renal Disorders  
Chapter 8.
Limb Disability
E .g . Peripheral Neuropathy 
See section: Drivers with 
disabilities Chapter 10.
See section: Disabled Drivers  
Chapter 10.
See appendix at end of this chapter
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Appendix — Chapter 4
The advice of Sláinte agus Tiomáint is made within the context of best available medical evidence, best current international 
practice, and EU and Irish law. They represent a minimum level of advice, and it is for others, for example, employers or 
directors of emergency services, to decide whether or how those recommendations should be interpreted for their own 
areas of interest, in the knowledge of their specific circumstances. The following sections represent how this is translated 
in terms of guidance to drivers with diabetes mellitus.
4 .1 A Guide for Drivers with Insulin Treated Diabetes or Oral Medications with Potential 
for Hypoglycaemia (such as sulfonylureas and glinides) who wish to apply for Group 2 
Licences (trucks and buses with or without trailer) entitlements .
Qualifying Conditions which must be met:
• No episode of hypoglycaemia requiring the assistance of another person has occurred in the preceding 12 months.
• Must have appropriate awareness of hypoglycaemia at appropriate glucose level. 
• Must demonstrate an understanding of the risks of hypoglycaemia. 
• Will not be able to apply until their condition has been stable for a period of at least one month. 
• Must regularly monitor their condition by checking their blood glucose levels at least twice daily and at times relevant 
to driving. A glucose meter with a memory function to measure and record blood glucose levels must be used. 
• At the annual examination by a consultant endocrinologist, 3 months of blood glucose readings must be available.
• Must have no other condition which would render them a danger when driving Group 2 vehicles. 
• They will be required to comply with the directions of doctors(s) treating the diabetes and to report immediately 
to the NDLS any significant change in their condition. 
 
4 .2 Information for Drivers with Diabetes Treated by Other Non-Insulin Medication,  
Diet or Both (For Group 1 and Group 2 Drivers)
Drivers do not need to tell the NDLS if their diabetes is treated by tablets (other than sulfonylureas and glinides, 
they should check with their doctor if uncertain), diet or both and that they are free of the complications listed below.
Some people with diabetes develop associated problems that may affect their driving.
Hypoglycaemia (low blood sugar)
Hypoglycaemia (also known as a hypo) is the medical term for a low blood glucose (sugar) level.
Severe hypoglycaemia means the assistance of another person is required. The risk of hypoglycaemia is the main danger 
to driving safety and can occur with diabetes treated with insulin or tablets or both. This may endanger your own life 
as well as that of other road users. Many of the accidents caused by hypoglycaemia are because drivers carry on driving 
even though they get warning symptoms of hypoglycaemia. If you get warning symptoms of hypoglycaemia while driving 
you must stop as soon as safely possible – do not ignore the warning symptoms.
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Early symptoms of Hypoglycaemia include
Sweating, shakiness or trembling, feeling hungry, fast pulse or palpitations, anxiety, tingling lips. If you do not treat this 
it may result in more severe symptoms such as:
Slurred speech, difficulty concentrating, confusion, disorderly or irrational behaviour, which may be mistaken for 
drunkenness. If left untreated, this may lead to loss of consciousness.
What you need to tell us about
You must tell us if any of the following applies:
• You have suffered more than one episode of severe hypoglycaemia within the last 12 months. You must also tell us 
if you or your medical team feel you are at high risk of developing severe hypoglycaemia. For Group 2 drivers (bus/
lorry), one episode of severe hypoglycaemia must be reported immediately. 
• You have developed an impaired awareness of hypoglycaemia (difficulty in recognising the warning symptoms of low 
blood sugar). 
• You suffer severe hypoglycaemia while driving. 
• You need treatment with insulin. 
• You don’t meet the vision standards set out in these Guidelines (See Chapter 7 for eyesight standards).
• You develop any problems with the circulation or sensation in your legs or feet which make it necessary for you to 
drive certain types of vehicles only, for example automatic vehicles or vehicles with a hand-operated accelerator or 
brake. This must be shown on your driving licence. 
• An existing medical condition gets worse or you develop any other condition that may affect your driving safely. 
In the interests of road safety, you must be sure that you can safely control a vehicle at all times .  
• If your doctor, specialist or optician tells you to report your condition to us. 
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4 .3 A Guide to Insulin Treated Diabetes and Driving
Drivers who have any form of diabetes treated with any insulin preparation must inform the NDLS .
Hypoglycaemia
Hypoglycaemia (also known as a hypo) is the medical term for a low blood glucose (sugar) level. Severe hypoglycaemia 
means that the assistance of another person is required. The risk of hypoglycaemia is the main danger to driving safety 
and this risk increases the longer you are on insulin treatment. This may endanger your own life as well as that of other 
road users. Many of the accidents caused by hypoglycaemia are because drivers carry on driving even though they get 
warning symptoms of hypoglycaemia. If you get warning symptoms of hypoglycaemia whilst driving, you must always 
stop as soon as safely possible – do not ignore the warning symptoms.
Early Symtoms of Hypoglcaemia include:
Sweating, shakiness or trembling, feeling hungry, fast pulse or palpitations, anxiety, tingling lips. If you do not treat this 
it may result in more severe symptoms such as:
Slurred speech, difficulty concentrating, confusion, disorderly or irrational behaviour, which may be mistaken for 
drunkenness. If left untreated this may lead to loss of consciousness.
Drivers with insulin treated diabetes are advised to take the following precautions:
• You must always carry your glucose meter and blood glucose strips with you. You must check your blood glucose 
before the first journey and every two hours whilst you are driving. 
• In each case if your blood glucose is 5 .0mmol/l or less, take a snack. If it is less than 4 .0mmol/l or you feel hypoglycaemic, 
do not drive. 
• If hypoglycaemia develops while driving, stop the vehicle as soon as possible. 
• You must switch off the engine, remove the keys from the ignition and move from the driver’s seat. 
• You must not start driving until 45 minutes after blood glucose has returned to normal. It takes up to 45 minutes for 
the brain to recover fully. 
• Always keep an emergency supply of fast-acting carbohydrate such as glucose tablets or sweets within easy reach in 
the vehicle. 
• You should carry personal identification to show that you have diabetes in case of injury in a road traffic accident. 
• Particular care should be taken during changes of insulin regimens, changes of lifestyle, exercise, travel and pregnancy. 
• You must take regular meals, snacks and rest periods on long journeys. Always avoid alcohol.  
Eyesight  
• See Chapter 7 for eyesight standards
Limb Problems
• Limb problems/amputations are unlikely to prevent driving. They may be overcome by driving certain types of vehicles 
e.g. automatics or one with hand controls.  
You must inform NDLS if: 
• You suffer more than one episode of severe hypoglycaemia (needing the assistance of another person) within the last 
12 months. For Group 2 drivers (bus/lorry) one episode of severe hypoglycaemia must be reported immediately. You 
must also tell us if you or your medical team feels you are at high risk of developing hypoglycaemia. 
• You develop impaired awareness of hypoglycaemia (difficulty in recognising the warning symptoms of low blood sugar).
• You suffer severe hypoglycaemia while driving. 
• An existing medical condition gets worse or you develop any other condition that may affect you driving safely.  
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Psychiatric Disorders Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Anxiety or depression
(Without significant memory 
or concentration problems, 
agitation, behavioural 
disturbance or suicidal 
thoughts).
NDLS need not be notified and 
driving may continue. 
(See note about medication in 
Appendix at end of this Chapter). 
Driver must notify NDLS if 
medical advice is to cease 
driving for 6 months or longer.
Very minor short-lived illnesses need 
not be notified to NDLS.
(See note about medication in 
Appendix at end of this Chapter). 
Driver must notify NDLS if medical 
advice is to cease driving for 6 
months or longer.
More severe anxiety states or 
depressive illnesses
(With significant memory 
or concentration problems, 
agitation, behavioural 
disturbance or suicidal 
thoughts).
N .B . For cases which also 
involve persistent misuse of or 
dependence on alcohol/drugs, 
please refer to the appropriate 
section of the alcohol/drugs 
chapter (Chapter 6). Where 
psychiatric illness has been 
associated with substance 
misuse, continuing misuse is not 
acceptable for licensing.
Driving should cease pending 
the outcome of medical enquiry. 
A period of stability depending 
upon the circumstances will be 
required before driving can be 
resumed. Particularly dangerous 
are those who may attempt 
suicide at the wheel.
Driver must notify NDLS if 
medical advice is to cease 
driving for 6 months or longer.
Driving should cease pending 
assessement by a consultant 
psychiatrist as being well and 
stable for a substantial period. 
Medication must not cause side 
effects which would interfere with 
alertness or concentration. Driving 
is usually permitted if the anxiety or 
depression is long-standing, but is 
controlled on doses of psychotropic 
medication which do not impair 
driving function. 
N .B . It is the illness rather than 
the medication, which is of prime 
importance, but see notes on 
medication. 
Driver must notify NDLS if medical 
advice is to cease driving for 6 
months or longer.
Chapter 5
Psychiatric disorders
Group 2 standards are minimum standards and do not preclude employers setting higher standards in terms of the demands 
of the driving tasks encountered in the course of employment.
See appendix at end of this chapter
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Psychiatric Disorders Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Acute Psychotic disorders  
of any type 
N .B . For cases, which also 
involve persistent misuse of or 
dependence on alcohol/drugs, 
please refer to the appropriate 
section of the alcohol/drugs 
chapter (Chapter 6). Where 
psychiatric illness has been 
associated with substance 
misuse, continuing misuse is not 
acceptable for licensing.
Driving must cease during the 
acute illness. Return to driving 
can be considered when all of 
the following conditions can be 
satisfied:
A. Has remained well and 
stable with an awareness of 
fitness to drive (i.e. to have 
experienced a good level 
of functional recovery with 
insight into their illness and 
including engagement with 
the medical services) before 
driving can be resumed.
B. Is not suffering from adverse 
effects of medication which 
would impair driving. In 
line with good practice, 
attempts should be made 
to achieve the minimum 
effective antipsychotic 
dose; tolerability should be 
optimal and not associated 
with any deficits (e.g. in 
alertness, concentration and 
motor performance) that 
might impair driving ability. 
Driver must notify NDLS if 
medical advice is to cease 
driving for 6 months or longer.
Driving must cease pending the 
outcome of medical assessment. 
It is a requirement that the 
person is assessed by a consultant 
psychiatrist. Return to driving can be 
considered when all of the following 
conditions can be satisfied:
A. Has remained well and stable 
with an awareness of fitness to 
drive (i.e. to have experienced a 
good level of functional recovery 
with insight into their illness and 
including engagement with the 
medical services) before driving 
can be resumed.
B. Is not suffering from adverse 
effects of medication which 
would impair driving. In line 
with good practice, attempts 
should be made to achieve the 
minimum effective antipsychotic 
dose; tolerability should be 
optimal and not associated with 
any deficits (e.g. in alertness, 
concentration and motor 
performance) that might impair 
driving ability. 
Driver must notify NDLS if  
medical advice is to cease  
driving for 6 months or longer.
See appendix at end of this chapter
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Psychiatric Disorders Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Hypomania/Mania
N .B . For cases, which also 
involve persistent misuse of or 
dependence on alcohol/drugs, 
please refer to the appropriate 
section of Chapter 6. Where 
psychiatric illness has been 
associated with substance 
misuse, continuing misuse is not 
acceptable for licensing.
Driving must cease during the 
acute illness. Return to driving 
can be considered when all of 
the following conditions can be 
satisfied:
A. Has remained well and 
stable with an awareness of 
fitness to drive (i.e. to have 
experienced a good level 
of functional recovery with 
insight into their illness and 
including engagement with 
the medical services) before 
driving can be resumed.
B. Is not suffering from adverse 
effects of medication which 
would impair driving. In 
line with good practice, 
attempts should be made 
to achieve the minimum 
effective antipsychotic 
dose; tolerability should be 
optimal and not associated 
with any deficits (e.g. in 
alertness, concentration and 
motor performance) that 
might impair driving ability. 
Driver must notify NDLS if 
medical advice is to cease 
driving for 6 months or longer. 
Repeated changes of mood: 
Hypomania or mania are 
particularly dangerous to 
driving when there are repeated 
changes of mood. In such cases 
a specialist opinion from a 
consultant psychiatrist is advised.
Driving must cease pending the 
outcome of medical assessment. 
It is a requirement that the 
person is assessed by a consultant 
psychiatrist. Return to driving can be 
considered when all of the following 
conditions can be satisfied:
A. Has remained well and stable 
with an awareness of fitness to 
drive (i.e. to have experienced a 
good level of functional recovery 
with insight into their illness and 
including engagement with the 
medical services) before driving 
can be resumed.
B. Is not suffering from adverse 
effects of medication which 
would impair driving. In line 
with good practice, attempts 
should be made to achieve the 
minimum effective antipsychotic 
dose; tolerability should be 
optimal and not associated with 
any deficits (e.g. in alertness, 
concentration and motor 
performance) that might impair 
driving ability. 
Driver must notify NDLS if medical 
advice is to cease driving for 6 
months or longer.
See appendix at end of this chapter
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Psychiatric Disorders Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Chronic Schizophrenia and  
other Chronic Psychoses
N .B . For cases, which also
involve persistent misuse of
or dependence on
alcohol/drugs, please refer
to the appropriate section of
Chapter 6. Where
psychiatric illness has been
associated with substance
misuse, continuing misuse is
not acceptable for licensing.
Return to driving can be 
considered when all of the 
following conditions can be 
satisfied:
A. Has remained well and 
stable with an awareness of 
fitness to drive (i.e. to have 
experienced a good level 
of functional recovery with 
insight into their illness and 
including engagement with 
the medical services) before 
driving can be resumed.
B. Is not suffering from adverse 
effects of medication which 
would impair driving. In line 
with good practice, attempts 
should be made to achieve 
the minimum effective anti-
psychotic dose; tolerability 
should be optimal and 
not associated with any 
deficits (e.g. in alertness, 
concentration and motor 
performance) that might 
impair driving ability.
Continued on next page
Driving must cease pending the 
outcome of medical assessment. 
It is a requirement that the 
person is assessed by a consultant 
psychiatrist. Return to driving can be 
considered when all of the following 
conditions can be satisfied:
A. Has remained well and stable 
with an awareness of fitness to 
drive (i.e. to have experienced a 
good level of functional recovery 
with insight into their illness and 
including engagement with the 
medical services) before driving 
can be resumed.
B. Is not suffering from adverse 
effects of medication which 
would impair driving. In line 
with good practice, attempts 
should be made to achieve 
the minimum effective anti-
psychotic dose; tolerability 
should be optimal and not 
associated with any deficits (e.g. 
in alertness, concentration and 
motor performance) that might 
impair driving ability. 
Continued on next page
See appendix at end of this chapter
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Psychiatric Disorders Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Chronic Schizophrenia and other 
Chronic Psychoses
Continued from previous page
Continuing symptoms:
Even with limited insight, these 
do not necessarily preclude 
licensing. Symptoms should 
be unlikely to cause significant 
concentration problems, 
memory impairment or 
distraction whilst driving. 
Particularly dangerous, are 
those drivers whose psychotic 
symptoms relate to other road 
users.
Driver must notify NDLS if 
medical advice is to cease 
driving for 6 months or longer. 
Due consideration should be 
given to specialist on-road 
assessment if doubt remains 
about fitness to drive.
Driver must notify NDLS if medical 
advice is to cease driving for 6 
months or longer.
Developmental disorders
Includes Asperger’s Syndrome, 
autism, severe communication 
disorders and Attention Deficit 
Hyperactivity Disorder.
A diagnosis of any of these 
conditions is not in itself a bar 
to licensing. Factors such as 
impulsivity, lack of awareness of 
the impact of own behaviours 
on self or others need to be 
considered.
It is normally a requirement that the 
person is assessed by a consultant 
psychiatrist. Continuing minor 
symptomatology may be compatible 
with licensing. Cases will be 
considered on an individual basis.
See appendix at end of this chapter
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Psychiatric Disorders Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Mild Cognitive Impairment (MCI) Where there is no objective 
impairment of function MCI 
does not need to be notified to 
NDLS. Where there is objective 
impairment of function or 
specific treatment is required 
then MCI will not be the cause 
and doctor should clarify the 
cause and apply the relevant 
section of Sláinte agus Tiomáint.
Given that a significant 
proportion of people with MCI 
progress to dementia over time, 
yearly review of diagnostic 
status is recommended.
If MCI is suspected a specialist 
opinion is required and at least 
yearly review.
Where there is no objective 
impairment of function MCI 
does not need to be notified to 
NDLS. Where there is objective 
impairment of function or specific 
treatment is required then MCI will 
not be the cause and doctor (it is 
normally a requirement that the 
person is assessed by a consultant 
psychiatrist, geriatrician or 
neurologist) should clarify the cause 
and apply the relevant section of 
Sláinte agus Tiomáint.
See appendix at end of this chapter
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Psychiatric Disorders Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Dementia or any Organic  
Brain Syndrome
It can be difficult to assess 
driving ability in those with 
dementia. Those who have 
poor short-term memory, 
disorientation, lack of insight 
and judgement are almost 
certainly not fit to drive.
The variable presentations 
and rates of progression are 
acknowledged. Disorders 
of attention will also cause 
impairment. A decision 
regarding fitness to drive is 
usually based on consultant 
medical assessment, further 
assessment by occupational 
therapy and/or neuropsychology, 
with a low threshold for an on-
road driving assessment.
In early dementia when 
sufficient skills are retained and 
progression is slow, a licence 
may be issued subject to annual 
review or sooner if a significant 
medical or functional decline 
is noted. A formal driving 
assessment is generally an 
integral part of assessment and 
review. 
Driver must notify NDLS.
See Section: 2.3.1 Chapter 1.
Not fit to Drive .
Driver must notify NDLS. 
See Section: 2.3.1 Chapter 1.
See appendix at end of this chapter
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Psychiatric Disorders Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Learning disability
Severely below average general 
intellectual functioning 
accompanied by significant 
limitations in adaptive 
functioning in at least two of the 
following areas: communication, 
self-care, home-living, social/
interpersonal skills, use of 
community resources, self-
direction, functional academic 
skills, work, leisure, health and 
safety.
Severe learning disability is not 
compatible with driving and 
the licence application must 
be refused. In milder forms, 
provided there are no other 
relevant problems, it may be 
possible to hold a licence.
Moderate and severe learning 
disability is not compatible with 
driving and the licence application 
must be refused. Minor degrees 
of learning disability when the 
condition is stable with no medical 
or psychiatric complications may be 
compatible with the holding of a 
licence.
Behaviour disorders 
Includes post head injury 
syndrome and Non-Epileptic 
Seizure Disorder.
If seriously disturbed e.g. violent 
behaviour or alcohol abuse and 
likely to be a source of danger 
at the wheel, driving must 
cease. After medical assessment 
confirms that behavioural 
disturbances have been 
satisfactorily controlled, driving 
can resume. 
Driver must notify NDLS if 
medical advice is to cease 
driving for 6 months or longer.
Not compatible with driving and 
the licence application must be 
refused if associated with serious 
behaviour disturbance likely to 
make the individual be a source of 
danger at the wheel. If assessment 
by consultant psychiatric confirms 
enduring stability, then return to 
driving can be considered. 
Driver must notify NDLS if medical 
advice is to cease driving for 6 
months or longer.
Personality disorders If likely to be a source of 
danger at the wheel cessation 
of driving is required or the 
application refused. Licensing 
may be permitted providing 
medical enquiry confirms that 
any behaviour disturbance is 
not related to driving or not 
likely to adversely affect driving 
or road safety.
Driver must notify NDLS if 
medical advice is to cease 
driving for 6 months or longer.
Cessation of driving is required or 
refusal of application if associated 
with serious behaviour disturbance 
likely to make the individual be 
a source of danger at the wheel. 
In such cases licensing can be 
considered if assessment by 
consultant psychiatrist confirms 
stability. 
Driver must notify NDLS if medical 
advice is to cease driving for 6 
months or longer.
See appendix at end of this chapter
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Appendix — Chapter 5
Psychiatric notes
Important Notes
Other psychiatric conditions, which do not fit neatly into the aforementioned classification, will need to be reported to 
the National Driver Licence Service (NDLS) if causing or felt likely to cause symptoms affecting driving safety. These would 
include for example any impairment of consciousness or awareness, any increased liability to distraction or symptoms 
affecting the safe operation of vehicle controls. The patient should be advised to declare both the condition and symptoms 
of concern.
It is the relationship of symptoms to driving that is of importance .
• Directive (91/439/EEC) as amended by Directive 2009/112/113/EC requires member states to set minimum medical 
standards of fitness to drive and sets out the requirements for mental health in broad terms.
• These Directives make a clear distinction between the standards needed for Group 1 (car and motorcycles) and Group 2 
(lorries and buses) licences. The standards for the latter being more stringent due to the size of vehicle and the greater 
time spent at the wheel during the course of the occupation.
• Severe mental disorder for the purposes of these Guidelines is defined as including mental illness, arrested or 
incomplete development of the mind, psychopathic disorder or severe impairment of intelligence or social functioning. 
The standards must reflect, not only the need for an improvement in the mental state, but also a period of stability, 
such that the risk of relapse can be assessed should the driver fail to recognise any deterioration, this is especially 
pertinent in the assessment of Group 2 licence.
• Misuse of or dependence on alcohol or drugs will require the standards in this chapter to be considered in conjunction 
with those of Chapter 6 of this publication.
Medication
• Any person who drives, attempts to drive or is in charge of a vehicle in a public place whilst under the influence of 
an intoxicant (including a drug or drugs) to such an extent as to be incapable of having proper control of the vehicle 
is liable to prosecution, as set out in the Road Traffic Acts. 
• All drugs acting on the central nervous system can impair alertness, concentration and driving performance. This 
is particularly so at initiation of treatment, or soon after and when dosage is being increased. Driving must cease if 
adversely affected until the patient is unimpaired.
• The older tricyclic antidepressants can have pronounced anticholinergic and antihistaminic effects, which may impair 
driving. The more modern antidepressants may have fewer adverse effects. These considerations need to be taken 
into account when planning the treatment of a patient who is a professional driver .
• Antipsychotic drugs, including the depot preparations, can cause motor or extrapyramidal effects as well as sedation 
or poor concentration, which may, either alone or in combination, be sufficient to impair driving. Careful clinical 
assessment is required.
• The epileptogenic potential of psychotropic medication should be considered particularly when patients are professional 
drivers.
• Benzodiazepines are the most likely psychotropic medication to impair driving performance, particularly the long 
acting compounds. Alcohol will potentiate the effects .
• Doctors and pharmacists have a duty of care to advise drivers of the potential dangers of adverse effects from medication 
and interactions with other substances, especially alcohol.
• Drivers with psychiatric illnesses are often safer when well and on regular psychotropic medication than when they 
are ill. Inadequate treatment or irregular compliance may render a driver impaired by both the illness and medication.
Confidentiality
See Part A, Introduction Chapter 1, Section 2.3.1
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Alcohol Problems Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Alcohol misuse
There is no single definition 
which embraces all the variables 
in this condition but the 
following is offered as a guide:
“A state which, because of 
consumption of alcohol, causes 
disturbance of behaviour, related 
disease or other consequences, 
likely to cause the patient, his/
her family or society harm now, 
or in the future, and which may 
or may not be associated with 
dependence”. 
Reference to ICD10 F10.1 is 
relevant.
Persistent alcohol misuse, 
confirmed by medical enquiry 
with or without evidence 
of otherwise unexplained 
abnormal blood biomarkers, 
requires cessation from driving 
until a minimum 3 month 
period of controlled drinking 
or abstinence has been 
attained, with normalisation of 
biomarkers, if relevant. 
Patient to seek advice from 
medical or other sources during 
the period off the road. 
Driver must notify NDLS.
Persistent alcohol misuse, 
confirmed by medical enquiry with 
or without evidence of otherwise 
unexplained abnormal blood 
biomarkers, requires cessation from 
driving until a minimum 1 year 
period of abstinence or controlled 
drinking has been attained, with 
normalisation of biomarkers, if 
relevant. 
 
Patient to seek advice from medical 
or other sources during the period 
off the road. 
Driver must notify NDLS.
Chapter 6
Drug and alcohol misuse and dependence
The presence of any of the conditions listed below requires the applicant or licence holder to inform the National Driver 
Licence Service (NDLS) unless stated otherwise in the text. Group 2 standards are minimum standards and do not preclude 
employers setting higher standards in terms of the demands of the driving tasks encountered in the course of employment.
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Alcohol Problems Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Alcohol dependence
“A cluster of behavioural, 
cognitive and physiological 
phenomena that develop after 
•  repeated alcohol use and 
which include a strong 
desire to take alcohol, 
• difficulties in controlling 
its use, 
• persistence in its 
use despite harmful 
consequences, with 
evidence of increased 
tolerance and sometimes a 
physical withdrawal state.” 
Indicators may include a history 
of withdrawal symptoms, of 
tolerance, of detoxification(s) 
and/or alcohol related fits.
Alcohol dependence, confirmed 
by medical enquiry, requires 
cessation from driving until 
a 6 month period free from 
alcohol has been attained with 
normalisation of biomarkers, if 
relevant. 
Driver must notify NDLS.
Return to Driving 
Will require satisfactory 
medical assessment from own 
doctor(s) and management of 
blood biomarkers if relevant. 
Consultant support/referral may 
be necessary.
See also under “Alcohol related 
seizures”.
Group 2 licence will not be granted 
where there is a history of alcohol 
dependence within the past 3 years. 
Driver must notify NDLS. 
Return to Driving
Will require satisfactory medical 
assessment from own doctor(s) and 
management of blood biomarkers 
if relevant. Consultant support/
referral may be necessary.
See also under “Alcohol related 
seizures”.
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Alcohol Problems Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Alcohol related seizures
Seizures associated with alcohol 
are not considered provoked for 
licensing purposes. 
Following a solitary alcohol-
related seizure, cessation 
from driving for a minimum 6 
month period from the date 
of the event. Should however 
the seizure have occurred on 
a background of alcohol, the 
standards for such conditions 
will need to be satisfied before 
a new application can be 
considered. Where more than 
one seizure has occurred, the 
epilepsy standards will apply 
(See Appendix to Neurology 
Chapter 2 for full details). Return 
to driving should only occur 
after an appropriate period 
free from persistent alcohol 
misuse and/or dependence. 
Independent medical 
assessment with management 
of blood biomarkers if relevant 
and consultant reports will 
normally be necessary.
Driver must notify NDLS.
Following a solitary alcohol-related 
seizure, a cessation from driving for 
a minimum 5 year period from the 
date of the event. 
Return to driving thereafter requires: 
• No underlying cerebral 
structural abnormality. 
• Off antiepileptic medication for 
at least 5 years. 
• Maintained abstinence from 
alcohol if previously dependent. 
• Review by an addiction specialist 
and neurological opinion. 
Where more than one seizure has 
occurred or there is an underlying 
cerebral structural abnormality, the 
Group 2 epilepsy standards apply. 
(See Appendix to Neurology Chapter 
for full details). 
Driver must notify NDLS.
Alcohol related disorders
E.g. Hepatic cirrhosis with 
neuro-psychiatric impairment, 
psychosis.
Driving should cease until there 
is satisfactory recovery and is 
able to satisfy all other relevant 
medical standards. 
Driver must notify NDLS.
Driving should cease . 
Driver must notify NDLS.
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Drug Misuse and Dependence
Reference to ICD10 F10 .1-F10 .7 
inclusive is relevant
Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Cannabis
The non-prescribed use of this 
drug and/or the use of supra- 
therapeutic dosage constitutes 
misuse/ dependence for 
licensing purposes. 
The prescribed use of medicinal 
cannabis at therapeutic doses 
(MIMS/BNF/PIL), without 
evidence of impairment, 
does not amount to misuse/
dependence for licensing 
purposes (although clinically 
dependence may exist). 
See also Chapter 1, s3.9.2 The 
effects of specific medicine 
classes
Persistent use of or dependence 
on these substances, confirmed 
by medical enquiry, requires 
cessation from driving until 
a minimum 3 month period 
free of such use has been 
attained. Independent medical 
assessment and drug screen may 
be required. There should be no 
evidence of continuing use of 
illicit substances. 
Driver must notify NDLS.
Persistent use of or dependence 
on these substances, confirmed by 
medical enquiry, requires cessation 
from driving until a minimum 
1 year period free of such use has 
been attained. Specialist medical 
assessment and drug screen may 
be required. There should be no 
evidence of continuing use of illicit 
substances.
Driver must notify NDLS.
Cocaine, Amphetamines, 
Methamphetamine
Ecstasy, ketamine & other 
psychoactive substances, 
including LSD and hallucinogens, 
psychoactive substances (Head 
shop products) .
Persistent use of or dependence 
on these substances, confirmed 
by medical enquiry, requires 
cessation from driving until 
a minimum 6 month period 
free of such use has been 
attained. Independent medical 
assessment and drug screen may 
be required. There should be no 
evidence of continuing use of 
illicit substances.
Driver must notify NDLS.
Persistent use of or dependence 
on these substances, confirmed by 
medical enquiry, requires cessation 
from driving until a minimum 
1 year period free of such use has 
been attained. Specialist medical 
assessment and drug screen may 
be required. There should be no 
evidence of continuing use of illicit 
substances.
Driver must notify NDLS.
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Drug Misuse and Dependence
Reference to ICD10 F10 .1-F10 .7 
inclusive is relevant
Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Heroin, Methadone* and other 
opiates including Codeine
The prescribed use of these 
drugs at therapeutic doses 
(MIMS/BNF), without evidence 
of impairment, does not amount 
to misuse/dependence for 
licensing purposes (although 
clinically dependence may exist).
Persistent use of, or dependence 
on these substances, confirmed 
by medical enquiry, requires 
cessation from driving until 
a minimum 6 month period 
free of such use has been 
attained. Independent medical 
assessment and drug screen may 
be required. There should be no 
evidence of continuing illicit use 
of such substances.
*Applicants or drivers who are 
complying fully and are stable 
on a supervised oral methadone 
substitution programme may 
continue to drive, subject 
to favourable assessment 
and annual medical review. 
Applicants or drivers on an oral 
buprenorphine programme may 
be considered applying the same 
criteria. There should be no 
evidence of continuing illicit use 
of such substances.
Driver must notify NDLS.
Persistent use of, or dependence 
on these substances, confirmed by 
medical enquiry requires cessation 
from driving until a minimum 3 
year period free of such use has 
been attained. Specialist medical 
assessment and drug screen will 
normally be required. 
*Applicants or drivers complying 
fully with a consultant supervised 
oral methadone maintenance 
programme may be considered for 
an annual review licence once a 
minimum 3 year period of stability 
on the maintenance programme 
has been established, with 
favourable random drug tests and 
assessment. There should be no 
evidence of continuing illicit use of 
such substances and no evidence of 
disorders of cognition, attention or 
insight.
Driver must notify NDLS.
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Drug Misuse and Dependence
Reference to ICD10 F10 .1-F10 .7 
inclusive is relevant
Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Benzodiazepines
The non-prescribed use of these 
drugs and/or the use of supra-
therapeutic dosage, whether 
in a substance withdrawal/
maintenance programme or 
otherwise, constitutes misuse/
dependence for licensing 
purposes.
The prescribed use of these 
drugs at therapeutic doses 
(MIMS/BNF), without evidence 
of impairment, does not amount 
to misuse/dependence for 
licensing purposes (although 
clinically dependence may exist).
Persistent misuse of, or 
dependence on these 
substances, confirmed by 
medical enquiry, requires driving 
cessation until a minimum 
6 month period free of such use 
has been attained. Independent 
medical assessment and drug 
screen may be required. In 
addition favourable consultant 
or specialist report may be 
required.
Driver must notify NDLS.
Persistent misuse of, or dependence 
on these substances, confirmed 
by medical enquiry, requires 
driving cessation until a minimum 
3 year period free of such use has 
been attained. Specialist medical 
assessment and drug screen may  
be required. 
Driver must notify NDLS.
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Drug Misuse and Dependence
Reference to ICD10 F10 .1-F10 .7 
inclusive is relevant
Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Seizure(s) associated with drug 
misuse/dependence 
Seizures associated with 
drug misuse/dependence are 
not considered provoked for 
licensing purposes.
Following a solitary seizure 
associated with drug misuse or 
dependence, driving must cease 
for a minimum 6 month period 
from the date of the event. 
Should however, the seizure 
have occurred on a background 
of substance misuse or 
dependence, the standards for 
such conditions will also need 
to be satisfied before return 
to driving. Where more than 
one seizure has occurred, the 
epilepsy standards will apply 
(See Appendix Neurology 
Chapter 2 for full details). 
Medical enquiry will be required 
before driving to confirm 
appropriate period free from 
persistent drug misuse and/
or dependence. Independent 
medical assessment with urine 
analysis and consultant reports 
will normally be necessary. 
Driver must notify NDLS.
Following a solitary seizure 
associated with drug misuse or 
dependence, driving must cease for 
a minimum 5 year period from the 
date of the event.
Return to driving thereafter requires:
• No underlying cerebral 
structural abnormality.
• Off antiepileptic medication for 
at least 5 years.
• Maintained abstinence from 
drugs if previously dependent.
• Review by an addiction specialist 
and neurological opinion.
Where more than one seizure has 
occurred, the epilepsy standards 
will apply (See Appendix Neurology 
Chapter 2 for full details). 
Driver must notify NDLS.
N .B . A person who has resumed driving following persistent drug misuse or dependence must be advised as 
part of their after-care that if their condition recurs they should cease driving and notify the NDLS.
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Visual Disorders Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Acuity Must have binocular visual 
acuity, with corrective lens as 
necessary, of at least 0.5 decimal 
(6/12 on a Snellen chart). 
If the patient has an illness 
likely to cause progressive loss 
of visual acuity the NDLS must 
be notified and on the advice of 
a competent medical authority, 
a 1 or 3 year licence may be 
appropriate.
Drivers must have a visual acuity, 
using corrective lenses if necessary, 
of at least 6/7.5 (0.8 decimal) in the 
better eye and at least 6/60 Snellen 
(decimal 0.1) in the other eye.
Where glasses are worn to meet  
the minimum standards, they 
should have a corrective power  
≤ +8 dioptres. 
It is also necessary for all drivers of 
Group 2 vehicles to be able to meet 
the prescribed and relevant Group 1 
visual acuity requirements.
Cataract
Includes severe bilateral 
cataracts, failed bilateral 
cataract extractions and post 
cataract surgery where these are 
affecting the eyesight.
Must be able to meet the acuity 
and visual field requirements, 
and more detailed specialist 
examination (see Appendix to 
this chapter, Item A) is indicated 
if there is concern that these are 
not adequately met. 
Must be able to meet the above 
prescribed acuity requirement. 
In the presence of cataract, glare 
may affect acuity and visual field 
requirements, and more detailed 
specialist examination (see Appendix 
to this chapter, Item A) is indicated 
if there is concern that these are not 
adequately met.
Chapter 7
Visual disorders
A licence holder or applicant must meet the standards for visual acuity and fields (assessed by a confrontation visual field test 
in the first instance) as outlined below, and if there is reason to doubt that these are adequate, the applicant or licence holder 
should undergo a more detailed examination by a specialist (an ophthalmologist or orthoptist or other medical practitioner 
with a special interest in defects of eyesight or optometrist) - see Appendix to this chapter, Item A, elements which should be 
assessed in more detailed assessment.
Group 2 standards are minimum standards and do not preclude employers setting higher standards in terms of the demands 
of the driving tasks encountered in the course of employment.
Bioptic telescope devices are not accepted for driving by the NDLS.
See appendix at end of this chapter
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Visual Disorders Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Monocular vision
(Includes the use of one eye only 
for driving)
Complete loss of vision in 
one eye (i.e. if there is any 
light perception, driver is not 
considered monocular). Must 
notify NDLS but may drive when 
clinically advised by a competent 
medical authority that driver 
has adapted to the disability and 
the prescribed eyesight standard 
in the remaining eye can be 
satisfied and there is a normal 
monocular visual field in the 
remaining eye, i.e. there is no 
area of defect which is caused by 
pathology. 
Driver must notify NDLS if 
medical advice is to cease 
driving for 6 months or longer.
Complete loss of vision in one eye 
or corrected acuity of less than 6/60 
(0.1 decimal) applicants may not 
hold a Group 2 licence.
Driver must notify NDLS if medical 
advice is to cease driving. 
See appendix at end of this chapter
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Visual Disorders Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Visual field defects
Disorders such as severe 
bilateral glaucoma, severe 
bilateral retinopathy, retinitis 
pigmentosa and other disorders 
producing significant field defect 
including partial or complete 
homonymous hemianopia/
quadrantanopia or complete 
bitemporal hemianopia.
Driving must cease unless 
confirmed that the horizontal 
visual field is at least 120 
degrees, the extension is at 
least 50 degrees left and right 
and 20 degrees up and down. 
No defects should be present 
within a radius of the central 20 
degrees. If the patient has an 
illness likely to cause progressive 
loss of visual field, NDLS must 
be notified and on advice by a 
competent medical authority, 
a 1 or 3 year licence may be 
appropriate.
See item B of Appendix at end 
of this chapter for guidance on 
more detailed assessment of 
visual fields. 
See item C of Appendix at end 
of this chapter for consideration 
as an exceptional case if not 
meeting these standards.
The horizontal visual field should be 
at least 160 degrees, the extension 
should be at least 70 degrees left 
and right and 30 degrees up and 
down. No defects should be present 
within a radius of the central 30 
degrees. 
It is recommended that formal 
perimetry is undertaken for  
Group 2 drivers.
See appendix at end of this chapter
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Visual Disorders Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Diplopia Cease driving on detection . 
Resume driving on confirmation 
to the NDLS that the diplopia 
is controlled by glasses (with 
or without a prism) or by 
a patch which the licence 
holder undertakes to wear 
while driving. (If patching, 
note requirements above for 
monocularity). 
Exceptionally a stable 
uncorrected diplopia of 
appropriate duration (for 
example, 6 months or more) 
may be compatible with 
driving if there is support 
from a competent medical 
authority indicating satisfactory 
functional adaptation. For 
treated decompensated phoria, 
driving can resume without 
informing the NDLS.
Cease driving on detection . 
Cease driving if permanent 
intractable diplopia. Patching is  
not acceptable.
Night blindness Acuity and field standards 
must be met. Cases should be 
considered on an individual basis 
by an appropriately qualified 
medical authority.
Group 2 acuity and field standards 
must be met and cases will then be 
considered on an individual basis.
Colour blindness Need not notify NDLS. Driving 
may continue with no restriction 
on licence.
Need not notify NDLS. Driving may 
continue with no restriction on 
licence.
See appendix at end of this chapter
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Appendix — Chapter 7
Visual notes
VISION REQUIREMENTS FOR HOLDING OF GROUP 1 LICENCE ENTITLEMENT
A) Elements which should be assessed in a more detailed assessment
Visual acuity, field of vision, twilight vision, glare and contrast sensitivity, diplopia and other visual functions that can 
compromise driving safety with no elevated risk: adjudication determined by clinical judgement. 
B) Guidance on formal field of vision testing
The minimum field of vision for driving safety is defined as “a field of at least 120° on the horizontal, measured using a 
target equivalent to the white Goldmann III4e settings. In addition, there should be no significant defect in the binocular 
field which encroaches within 20° of fixation above or below the horizontal meridian”.
This means that homonymous or bitemporal defects which come close to fixation, whether hemianopic or quadrantanopic, 
are not normally accepted as safe for driving.
If a visual field assessment is necessary to determine fitness to drive, a number of tests are possible: in the UK and 
Australia, for example, a binocular Esterman field is recommended. Monocular full field charts may also be requested in 
specific conditions. Exceptionally, Goldmann perimetry, carried out to strict criteria, will be considered. For an Esterman 
binocular chart to be considered reliable for licensing, the false positive score must be no more than 20%. When assessing 
monocular charts and Goldmann perimetry, fixation accuracy will also be considered.
Defect affecting central area ONLY
Pending the outcome of current research, the following are generally regarded as acceptable central loss as measured 
by the Esterman field method:
• Scattered single missed points.
• A single cluster of up to 3 adjoining points.
The following are generally regarded as unacceptable (i.e. ‘significant’) central loss as measured by the Esterman field 
method:
• A cluster of 4 or more adjoining points that is either wholly or partly within the central 20 degree area.
• Loss consisting of both a single cluster of 3 adjoining missed points up to and including 20 degrees from fixation, and 
any additional separate missed point(s) within the central 20 degree area.
• Any central loss that is an extension of a hemianopia or quadrantanopia of size greater than 3 missed points.
Defect affecting the peripheral areas – width assessment
The following will be disregarded when assessing the width of field:
• A cluster of up to 3 adjoining missed points, unattached to any other area of defect, lying on or across the horizontal 
meridian.
• A vertical defect of only single point width but of any length, unattached to any other area of defect, which touches 
or cuts through the horizontal meridian.
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C) Exceptional cases which can be considered for Group 1 drivers only
Drivers who have previously held full driving entitlement, removed because of a field defect which does not satisfy the 
standard, may be eligible to be considered as exceptional cases on an individual basis by a medical eye doctor,subject 
to strict criteria:
• The defect must have been present for at least 12 months.
• The defect must have been caused by an isolated event or a non-progressive condition. 
• There must be no other condition or pathology present which is regarded as progressive and likely to be affecting the 
visual fields. 
• The applicant has sight in both eyes.
• There is no uncontrolled diplopia.
• There is no other impairment of visual function, including glare sensitivity, contrast sensitivity or impairment of 
twilight vision. 
In order to meet the requirements of European law, to provide a driving licence certificate for 1, 3 or 10 years the NDLS 
will, in addition, require: 
• Clinical assessment of full satisfactory functional adaptation.
• A satisfactory practical driving assessment, carried out by an appropriately qualified driving assessor, must subsequently 
be completed.
Note: 
• An individual who is monocular cannot be considered under exceptional case criteria.
• D501 (Medical Report) or D502 (Eyesight Report) are only accepted by the NDLS if printed and signed as double-sided 
documents. 
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Renal Disorders Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Chronic Renal Failure +CAPD 
(Continuous ambulatory 
peritoneal dialysis) 
Haemodialysis
No restriction on holding a 
10 year licence, or if over 60 
a licence that expires at age 
70 unless subject to severe 
electrolyte disturbance or 
significant symptoms, e.g. 
sudden disabling attacks of 
dizziness or fainting or impaired 
psychomotor or cognitive 
function when driving should 
cease until the symptoms are 
controlled.
Hemodialysis patients should 
not travel distances more than 
1—2 days driving time from 
their home without making 
arrangements for dialysis at 
another centre. 
They should not drive for at least 
24 hours after missing a dialysis 
treatment, and resume driving 
when dialysis resumed and 
condition stabilised.
Driver must notify the NDLS.
Drivers with these disabilities will 
be assessed individually by their 
treating specialist (consultant 
nephrologist) against the criteria as 
shown in the Group 1 entitlement.
Driver must notify the NDLS.
All other Renal Disorders Need not notify NDLS unless 
associated with a relevant 
disability.
Need not notify NDLS unless 
associated with significant 
symptoms or a relevant disability.
Chapter 8
Renal disorders
Group 2 standards are minimum standards and do not preclude employers setting higher standards in terms of the demands 
of the driving tasks encountered in the course of employment.
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Respiratory and  
Sleep Disorders
Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Sleep Disorders
Including moderate or severe 
Obstructive Sleep Apnoea 
Syndrome causing excessive 
daytime/awake time sleepiness 
(while driving). 
A moderate obstructive sleep 
apnoea syndrome corresponds 
to a number of apnoeas and 
hypopnoeas per hour (Apnoea-
Hypopnoea Index) between 15 
and 29 and a severe obstructive 
sleep apnoea syndrome 
corresponds to an Apnoea-
Hypopnoea Index of 30 or more, 
both associated with excessive 
daytime sleepiness 
Refer to Chapter 2 Neurology re 
Narcolepsy
Driving must cease until 
satisfactory control of symptoms 
has been attained with ongoing 
compliance with treatment, 
confirmed by medical opinion. 
Periodic Medical review, 1-3 year 
licence may be granted.
Driver must notify NDLS.
Driving must cease until satisfactory 
control of symptoms has been 
attained, with ongoing compliance 
with treatment, confirmed by 
specialist medical opinion. 
Regular, normally annual, licensing 
review required.
Driver must notify NDLS.
Primary/Central Hypersomnias
Including Narcoleptic syndromes
See Chapter 2 Neurology. See Chapter 2 Neurology.
Respiratory Disorders
Including asthma, COPD (Chronic 
Obstructive Pulmonary Disease) 
and Cough Syncope.
NDLS need not be notified unless 
attacks are associated with 
disabling dizziness, fainting or 
loss of consciousness.
NDLS need not be notified unless 
attacks are associated with disabling 
dizziness, fainting or loss of 
consciousness.
Carcinoma of Lung NDLS need not be notified unless 
cerebral secondaries are present.
(See Chapter 2 for Malignant 
Brain Tumour).
Those drivers with non small cell 
lung cancer classified as T1N0M0 
can be considered on an individual 
basis. In other cases, driving must 
cease until 2 years has elapsed from 
the time of definitive treatment. 
Fit to drive providing treatment 
satisfactory and no brain scan 
evidence of intracranial metastases.
Chapter 9
Respiratory and sleep disorders
Group 2 standards are minimum standards and do not preclude employers setting higher standards in terms of the demands 
of the driving tasks encountered in the course of employment.
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Miscellaneous Conditions Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
Deafness (Profound) Need not notify NDLS. Of paramount importance is 
the proven ability to be able to 
communicate in the event of an 
emergency by speech or by using a 
device e.g. a MINICOM. If unable to 
do so likely to be unfit to drive. 
Driver must notify NDLS.
Brain Tumours Please refer to the appropriate 
section of Chapter 2.
Please refer to the appropriate 
section of Chapter 2.
All Cancers not already  
covered in earlier sections
For all tumours, fitness to drive 
depends upon:
• The prospective risk of a 
seizure:
NDLS does not need to be 
notified unless there are cerebral 
metastases or significant 
complications of relevance 
(see subsequent bullet points for 
guidance).
• Specific limb impairment, 
e.g. from bone primary or 
secondary cancer.
• General state of health. 
Advanced malignancies 
causing symptoms such 
as general weakness or 
cachexia to such an extent 
that driving would be 
comprised.
For all tumours, fitness to drive 
depends upon:
• The prospective risk of a seizure:
Specific attention is paid to the risk 
of cerebral metastasis.
• Specific limb impairment, e.g. 
from bone primary or secondary 
cancer.
• General state of health. 
Advanced malignancies causing 
symptoms such as general 
weakness or cachexia to such 
an extent that driving would be 
comprised.
For Group 2 entitlement (ODL), 
specific attention is paid to the 
risk of cerebral metastasis. For eye 
cancers, the vision requirements 
must be met as well as the above.
Chapter 10
Miscellaneous Conditions
Group 2 standards are minimum standards and do not preclude employers setting higher standards in terms of the demands 
of the driving tasks encountered in the course of employment.
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Miscellaneous Conditions Group 1 Entitlement ODL
car, motorcycle and tractor
Group 2 Entitlement ODL
AIDS Syndrome Driving may continue providing 
medical enquiries confirm no 
relevant associated disability 
(e.g. neurological or vision 
disorders) likely to affect driving. 
1 or 3 year licence with medical 
review. Need not notify NDLS.
Cases will be assessed on an 
individual basis by the supervising 
consultant.
Need not notify NDLS.
HIV Positive Need not notify NDLS. 
See Section 3.5: Multiple 
Conditions.
Need not notify NDLS. 
See Section 3.5: Multiple  
Conditions.
Age (Older Drivers) Age is no bar to the holding of a 
licence and physical frailty is not 
per se a bar to the holding of a 
licence.
See Section 3.5 on multiple 
morbidity, and relevant specific 
section for relevant diseases 
which are more common later 
in life, such as stroke and 
dementia.
See Chapter 1: Table 4.
Age is no bar to the holding of a 
licence and physical frailty is not per 
se a bar to the holding of a licence.
See Section 3.5 on multiple 
morbidity, and relevant specific 
section for relevant diseases which 
are more common later in life, such 
as stroke and dementia.
See Chapter 1: Table 4.
Hypoglycaemia
From any cause other than the 
treatment of diabetes
If suffering episodes of severe 
hypoglycaemia should cease 
driving while liable to these 
episodes. Examples would 
include after bariatric surgery 
or in association with eating 
disorders.
If suffering episodes of severe 
hypoglycaemia should cease driving 
while liable to these episodes. 
Examples would include after 
bariatric surgery or in association 
with eating disorders.
See appendix at end of this chapter
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Drivers with disabilities
Group 1 Car and Motorcycles
Driving is possible in both static and progressive or relapsing disorders but vehicle modification may be needed.
1. Permanent Limb Disabilities/Spinal Disabilities.
 e.g. amputation, hemiplegia/cerebral palsy, ankylosing spondylitis, severe arthritis, especially with pain.
2. Chronic Neurological Disorders:
e.g. multiple sclerosis, parkinson’s disease, motor neurone disease, peripheral neuropathy.
Sophisticated vehicle adaptation is now possible and varies from automatic transmission to joy sticks and infra red controls 
for people with severe disabilities.
The NDLS requires notification of which, if any, of the controls required to be modified. The driving licence will then be 
coded to reflect the modifications. 
Group 2 Entitlement ODL truck and bus (with or without trailer)
Some disabilities may be compatible with the driving of large vehicles if mild and non-progressive. Individual assessment 
will be required.
The National Programme Office for Traffic Medicine is reviewing the current situation of assessments of driving and 
adaptation of vehicles in Ireland . 
Useful resources
Location Available
RSA and NDLS web resources and email
www .rsa .ie/ie 
medicalfitness@rsa .ie
and 
www .ndls .ie
• D501 Medical Report
• D502 Eyesight Report
• Patient Advisory Form
• RSA Medical Pages – RSA only
• Road safety statistics – RSA only
NPOTM web resources at
www .rcpi .ie/trafficmedicine 
• Certificate in Traffic Medicine (14 CPD) Online and 
one day workshop
• Links to other international Guidelines
• Free Online Moodle CPD tool on Guidelines (3CPD)
• Traffic Medicine Ezine
• Upcoming Education Events
• Traffic Medicine Research
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Index
A 
ABSCESS (INTRACEREBRAL) - Neuro Chapter 2 – p. 42 
ACOUSTIC NEUROMA/SCHWANNOMA - Neuro Chapter 2 – p. 31 
ACUITY - Introduction Chapter 1, Diabetes Chapter 4 and Vision Chapter 7 – pp. 14, 61-64, 84-88 
ACUTE CORONARY SYNDROMES - Cardio Chapter 3 – p. 48 
ACUTE PSYCHOTIC DISORDERS OF ANY TYPE - Psyc Chapter 5 – p. 69 
AGE (OLDER DRIVERS) - Misc Chapter 10 – p. 93 
AIDS - Misc Chapter 10 – p. 93 
ALCOHOL MISUSE/DEPENDENCE – Drugs & Alcohol Chapter 6 – p. 77 
ALCOHOL SEIZURES/DISORDERS - Drugs & Alcohol Chapter 6 – p. 79 
ALZHEIMERS DISEASE - Psyc Chapter 5 – pp. 7 & 84 
ANEURYSM (AORTIC) - Cardio Chapter 3 – p. 54 
ANGINA (STABLE OR UNSTABLE) - Cardio Chapter 3 pp. 47, 48, 59 
ANGIOGRAPHY (CORONARY) - Cardio Chapter 3 p.60 
ANTIDEPRESSANTS– Introduction Chapter 1, Psyc Chapter 5 pp.15, 16, 76 
ANTIPSYCHOTICS – Introduction Chapter 1 p.16 
ANXIETY - Psyc Chapter 5 p.68 
AORTIC DISSECTION (CHRONIC) Cardio Chapter 3 p.55 
ARACHNOID CYSTS - Neuro Chapter 2 p.28 
ARRHYTHMIA - Cardio Chapter 3 pp.50-54 
ARTERIOVENOUS MALFORMATION- Neuro Chapter 2 p.38 
ASPERGER’S SYNDROME - Psyc Chapter 5 p.72 
ASTHMA – Respiratory Chapter 9 p.91 
ATRIAL FLUTTER/FIBRILLATION – Cardio Chapter 3 p.50 
ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) – Psyc Chapter 5 p.72 
AUTISM – Psyc Chapter 5 p.72 
AUTISTIC SPECTRUM DISORDER – Psyc Chapter 5 p.72
B 
BEHAVIOUR DISORDERS – Psyc Chapter 5 p.75 
BENIGN INFRATENTORIAL TUMOUR – Neuro Chapter 2 p.31 
BENIGN SUPRATENTORIAL TUMOUR – Neuro Chapter 2 p.29 
BENZODIAZEPINES – Introduction Chapter 1, Psyc Chapter 5, Drugs & Alcohol Chapter 6 pp.15, 16, 76, 82 
BRAIN TUMOURS – Neuro Chapter 2 and Misc Chapter 10 pp.32, 92
 
C 
CABG – Cardio Chapter 3 p.49 
CANCER OTHER – Misc Chapter 10 pp.13.91,92 
CAPD (continuous ambulatory peritoneal dialysis) – Renal Chapter 8 p.90 
CARCINOMA OF LUNG – Respiratory Chapter 9 p.91 
CARDIO RESYNCHRONISATION THERAPY (CRT) Cardio Chapter 3 p.57 
CARDIOMYOPATHY (Hypertrophic) – Cardio Chapter 3 p. 56,60 
CARDIOMYOPATHY (Dilated) – Cardio Chapter 3 p.56 
CATARACT – Vision Chapter 7 p. 84 
CATHETER ABLATION – Cardio Chapter 3 p.50 
CAVERNOUS MALFORMATION – Neuro Chapter 2 p.40 
CHRONIC NEUROLOGICAL DISORDERS – Neuro Chapter 2, Misc Chapter 10 pp 24, 94 
CHRONIC RENAL FAILURE –Renal Chapter 8 p.90
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CHRONIC SUBDURAL – Neuro Chapter 2 p. 34 
COPD (chronic obstructive pulmonary disease) –Respiratory Chapter 9 p.91 
COLOUR BLINDNESS – Vision Chapter 7 p.87 
COLLOID CYSTS – Neuro Chapter 2 p.28 
CONGENITAL HEART DISEASE – Cardio Chapter 3 p.58 
CORONARY ANGIOGRAPHY – Cardio Chapter 3 p.60 
COUGH SYNCOPE – Respiratory Chapter 9 p.91 
CRANIOTOMY – Neuro Chapter 2 pp. 28,29,30,31,34,36,37,38,39, 41
D 
DEFIBRILLATOR – CARDIOVERTER – Cardio Chapter 3 pp.51-53 
DEAFNESS – Misc Chapter 10 p.92 
DEMENTIA – Introduction Chapter 1,Psyc Chapter 5, Misc Chapter 10 pp.7,9,10,73,74,93 
DEPRESSION – Introduction Chapter 1, Psyc Chapter 5 pp16,68. 
DEVELOPMENTAL DISORDERS – Psyc Chapter 5 .p72 
DIABETES – ALL ASPECTS – Introduction Chapter 1,Diabetes Chapter 4, Misc Chapter 10 pp.2,3,5,10,13,15,61-67,93 
DIABETES Appendix – Diabetes Chapter 4 – pp. 65-67 
DIPLOPIA – Vision Chapter 7 pp.87,88,89 
DRIVERS WITH DISABILITIES – Drivers with disabilities Chapter 10 pp.14,94 
DIZZINESS – Neuro Chapter 2, Renal Chapter 8 pp.25,90,91 
DRIVING AFTER SURGERY – Introduction Chapter 1 p.12 
DRUG MISUSE/DEPENDENCY – Introduction Chapter 1,Drugs & Alcohol Chapter 6 pp.15,46,80-83 
DURAL AV FISTULA – Neuro Chapter 2 p.40
E 
ECG ABNORMALITY – Cardio Chapter 3 p.58 
ECLAMPTIC SEIZURES – Neuro Chapter 2 p.46 
ENCEPHALITIC ILLNESS – Neuro Chapter 2 p.27 
EPILEPSY –Introduction Chapter 1, Neuro Chapter 2,Drugs & Alcohol Chapter 6 pp.2,3,5,10,15,18-22,27,29,30,40-42,44-46,79,83 
EPILEPSY STANDARDS – Neuro Chapter 2 pp.44-46 
ETT and HYPERTROPHIC CARDIOMYOPATHY – Cardio Chapter 3 p.60 
EXCESSIVE SLEEPINESS – Respiratory Chapter 9 p.91 
EXERCISE TESTING – Neuro Chapter 2,Cardio Chapter 3 pp.22,56,59,60 
EXTRAVENTRICULAR DRAIN – Neuro Chapter 2 p.42
F 
FIELD OF VISION REQUIREMENTS – Vision Chapter 7 pp.86,88,89 
G 
GLAUCOMA – Vision Chapter 7 p.13,86 
GLIOMAS – Neuro Chapter 2 p.31,32
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H 
HAEMATOMA – INTRACEREBRAL – Neuro Chapter 2, p33 
HEAD INJURY – TRAUMATIC– Neuro Chapter 2, Psyc Chapter 5 pp.20,27,33,46,75 
HEART FAILURE – Cardio Chapter 3 p.57 
HEART VALVE DISEASE – Cardio Chapter 3 p.59 
HEMIANOPIA – Vision Chapter 7 p.86,88 
HIV POSITIVE – Misc Chapter 10 p.93 
HUNTINGTONS DISEASE – Chronic Neurological disorders -Neuro Chapter 2– Misc Chapter 10 p.14,16 
HYDROCEPHALUS – Neuro Chapter 2 p.42 
HYPERTENSION – Cardio Chapter 3 p.12,55,59 
HYPERTROPHIC CARDIOMYOPATHY – Cardio Chapter 3 p.56,60 
HYPOGLYCAEMIA – Diabetes Chapter 4– Misc Chapter 10 pp.61-67 
HYPOMANIA/MANIA – Psyc Chapter 5 p.70
I 
ICD – Introduction Chapter 1,Cardio Chapter 3 p.10,51,52,53,54,56,57 
IMPAIRMENT DUE TO MEDICATION – Introduction Chapter 1 pp.15,16,76 
IMPAIRMENT OF COGNITIVE FUNCTION – Introduction Chapter 1- Psyc Chapter 5 pp. 9.10,13,16,24,26,33,34,35,38,41,73,78,90 
IMPAIRMENT SECONDARTY TO MULTIPLE MEDICAL CONDITIONS – Introduction Chapter 1 p.13 
IMPLANTED ELECTRODES – Neuro Chapter 2 p.43 
INFRATENTORIAL AVMs – Neuro Chapter 2 p.39 
INTRACEREBRAL ABSCESS – Neuro Chapter 2 p.42 
INTRACRANIAL PRESSURE MONITOR – Neuro Chapter 2 p. 43 
INTRAVENTRICULAR SHUNT – Neuro Chapter 2 p.42 
ISOLATED SEIZURE – Neuro Chapter 2 p. 18-20,44-46
 
L 
LEARNING DISABILITY – Psyc Chapter 5 p.75 
LEFT VENTRICULAR ASSIST DEVICES – Cardio Chapter 3 p.48,49,60 
LOSS OF CONSCIOUSNESS/LOSS OF OR ALTERED AWARENESS – Neuro Chapter 2, Diabetes Chapter 4, Respiratory Chapter 
9 p.21,22,23,66,67,91
 
M 
MALIGNANT TUMOURS – Neuro Chapter 2 p.31 
MEDICAL CANNABIS– Introduction Chapter 1 p.16 
MENINGIOMA – Neuro Chapter 2 pp. 29, 30, 31 
MILD COGNITIVE IMPAIRMENT (MCI) – Psyc Chapter 5 p p.73 
MONOCULAR VISION – Vision Chapter 7 p p.85, 88, 89 
MOTOR CORTEX STIMULATOR – Neuro Chapter 2 p. 43 
MOTOR NEURONE DISEASE – Neuro Chapter 2– Drivers with disabilities Chapter 10 p p.24, 94 
MULTIPLE SCLEROSIS - Introduction Chapter , Neuro Chapter 2– Drivers with disabilities Chapter 10 p p. 14,16,24,94 
MUSCLE DISORDERS - Neuro Chapter 2 pp. 24,26,33 
MYOCARDIAL INFARCTION – Cardio Chapter 3 pp. 58, 62
N 
NEUROENDOSCOPIC PROCEDURES – Neuro Chapter 2 p. 43 
NIGHT BLINDNESS – Vision Chapter 7 p. 87 
NON-EPILEPTIC SEIZURE ATTACKS – Neuro Chapter 2, Psyc Chapter 5 pp. 20,75
 
O 
OBSTRUCTIVE SLEEP APNOEA SYNDROME – Misc Chapter 10 p. 91 
OPIOIDS – Introduction Chapter 1 p.16 
ORGANIC BRAIN SYNDROME – Psyc Chapter 5 p. 74
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P 
PACEMAKER IMPLANT – Cardio Chapter 3 pp. 50, 56 
PARKINSONS DISEASE Introduction Chapter 1, Neuro Chapter 2
DRIVERS WITH DISABILITIES Chapter 10 pp.10, 15, 24, 94 
PERCUTANEOUS CORONARY INTERVENTION – Cardio Chapter 3 p.49 
PERIPHERAL NEUROPATHY – Diabetes Chapter 4,DRIVERS WITH DISABILITIES Chapter 10 pp.64,94 
PERSONALITY DISORDER – Psyc Chapter 5 p. 75 
PITUITARY TUMOUR – Neuro Chapter 2 p. 29 
PRIMARY/CENTRAL HYPERSOMIAS – Respiratory Chapter 9 p. 91 
PROVOKED SEIZURES – Neuro Chapter 2 pp. 20,46 
PSYCHIATRIC NOTES – Psyc Chapter 5 p.76 
PSYCHOSIS – Psyc Chapter 5 p79
 
R 
REFLEX VASOVAGAL SYNCOPE – Neuro Chapter 2 p.21 
RENAL DISORDERS –Renal Chapter 8 p.90 
RESPIRATORY DISORDERS – Respiratory Chapter 9 p91.
S 
SCHIZOPHRENIA – Psyc Chapter 5 pp.71, 72 
SEIZURES – Neuro Chapter 2– Drugs & Alcohol Chapter 6 pp.20,26,27,28, 29, 30, 33,44,45,46,79,83 
SPONTANEOUS ACUTE SUBDURAL HAEMATOMA – Neuro Chapter 2 p.34 
STROKES/TIAs – Neuro Chapter 2 pp.26, 43, 46 
SUBARACHNOID HAEMORRHAGE – Neuro Chapter 2 pp. 21.35.36.37 
SUBDURAL EMPYEMA – Neuro Chapter 2 p.42 
SUBSTANCE MISUSE - Introduction Chapter 1,Neuro Chapter 2– Psyc Chapter 5 Drugs & Alcohol Chapter 6 pp.3,10, 15,68-71,83 
SUPRATENTORIAL AVMs – Neuro Chapter 2 p.40 
SYNCOPAL ATTACKS – Neuro Chapter 2,Cardio Chapter 3 – Respiratory Chapter 9 p.46, 58, 59, 91
T 
TAXI LICENSING – Introduction Chapter 1 p.17 
TIA – Neuro Chapter 2 pp.26,43, 46 
TRANSIENT GLOBAL AMNESIA Neuro Chapter 2 p.27 
TRANSIENT ARRHYTHMIAS – Cardio Chapter 3 p. 50 
TRANSPHENOIDAL SURGERY – Neuro Chapter 2 p. 29 
TRAUMATIC BRAIN INJURY – Neuro Chapter 2 p. 33
 
U 
UNPACED CONGENITAL COMPLETE HEART BLOCK – Cardio Chapter 3 p.51
 
V 
VALVE HEART DISEASE – Cardio Chapter 3 pp.59, 60 
VENTRICULAR CARDIOMYOPATHY – Cardio Chapter 3 p.56 
VISUAL ACUITY – Introduction Chapter 1, Diabetes Chapter 4, Vision Chapter 7 pp. 14, 63, 64, 84, 88 
VISUAL FIELD DEFECTS –– Neuro Chapter 2, Vision Chapter 7 pp.26, 86 
VISUAL FIELD REQUIREMENTS – Vision Chapter 7 p.88
 
W 
WITHDRAWAL OF ANTI-EPILEPSY MEDICATION – Neuro Chapter 2 pp.45,46
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Patient Advisory Form 
Dear 
Following your assessment today, _____ /_____ /_____, I am advising you that you need to contact your National Driver Licence 
Service to let them know that you have a condition _____________________ which may impact on your fitness to drive: 
I am also advising that: 
The philosophy of the NDLS is an enabling one, aiming to maximise mobility of drivers to the greatest extent possible. However, 
it is important to ensure that an appropriate balance is found between mobility and safety and the NDLS is likely to request you to 
provide a medical report clarifying your medical fitness to drive once you have notified them. The conditions that require reporting 
to your NDLS are outlined in the declaration made by you when you applied for, or renewed, your driving licence (see below) and 
also in the official RSA guidelines for medical fitness to drive, Sláinte agus Tiomáint. You should also clarify with your insurer as to 
whether or not this condition needs to be reported to them as well. A record of  
this notification will be held in your medical file here.
Yours sincerely
1.	 Diabetes	treated	by	insulin	and	or	sulphonylurea	tablets	(doctor	to	advise	
whether	patient	is	on	these	or	not)	no	need	to	tell	us	if	managed	by	other	tablets	
and	or	diet	
2.	 Epilepsy
3.	 Stroke	or	TIAs	with	any	associated	symptoms	lasting	longer	than	one	month
4.	 Fits	or	blackouts
5.	 Any	type	of	brain	surgery,	brain	abscess	or	severe	head	injury	involving		
in-patient	treatment	or	brain	tumour	or	spinal	injury	or	spinal	tumour
6.	 An	implanted	cardiac	pacemaker
7.	 An	implanted	cardiac	defibrillator	(ICD)
8.	 Repeated	attacks	of	sudden	disabling	dizziness	
9.	 Any	other	chronic	neurological	condition	such	as	multiple	sclerosis,		
motor	neurone	disease,	Parkinson	disease	and	Huntington’s	disease	
10.	 A	serious	problem	with	memory	or	periods	of	confusion.
11.	 Persistent	alcohol	misuse	or	dependency
12.	 Persistent	drug	misuse	or	dependency
13.		 Serious	psychiatric	illness	or	mental	health	problems
15.		 Sleep	Apnoea	Syndrome
16.		 Narcolepsy
17.		 Any	condition	affecting	the	drivers	peripheral	vision	
18.		 Total	loss	of	sight	in	one	eye
19.		 Any	condition	affecting	both	eyes,	or	the	remaining	eye	if	driver	only	has	one	eye	
(Not	including	colour	blindness	or	short	or	long	sight)	
20.		 A	serious	hearing	deficiency
21.		 Any	persisting	problem	with	arm(s)	or	leg(s)	which	needs	driving	to	be		
restricted	to	certain	types	of	vehicle	or	those	with	adapted	controls	
22.		 Is	the	driver’s	vehicle	adapted	because	of	a	physical	disability	to	enable	
	you	to	drive	
23.		 Severe	learning	disability
The above list is not exhaustive
Please note if you are the holder of an EU licence from a country other than Ireland, or hold a licence from a recognised country for licence exchange  
purposes, you should contact the NDLS to arrange for a licence exchange and medical report.
Medical conditions requiring declaration at application for and renewal of driving licence
And recommend a further specialist opinion                   Yes                            No

Sláinte agus Tiomáint
Medical Fitness To Drive Guidelines
 (Group 1 and Group 2 Drivers)
(4th Ed) March 2015,  
replaces previous editions  
and the document  
Medical Aspects of Driver licensing:  
A Guide for Medical Practitioners 2010 .
Summary of Amendments
Edition April 2014 v March 2015 
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Location in Text Original text Replacement or additional text
Throughout document Safe driving - changed Driving safety and or elevate risk of 
impairment while driving
Location in Text Original text Replacement or additional text
Table of Contents: Changed As per table of contents
Legal Disclaimer ii …While in general, a limited number of 
sections relating to diabetes, epilepsy 
and vision, have the force of law, by 
virtue of the confirmation of the 2009 
Directive into regulations 12 …
A limited number of sections relating 
to diabetes, epilepsy vision and 
neurology disease and obstructive 
sleep apnoea syndrome as set 
by 2009/113/EC and 2014/85/
EU Directives (amending Directive 
2006/126/EC) have the force of law 
implemented by regulations 12 and 
20 of the Road Traffic (Licensing of 
Drivers) Regulations 2006…
1  .0 
Acknowledgements
Some changes in Working Group 
member representation
As per acknowledgements
Chapter 1 Additional footnotes and changes to 
original footnotes
Footnotes – see all
SUMMARY OF AMENDMENTS 2014 Edition 
Changes throughout document (Group 1 Drivers) Edition Feb 2013 v April 2014 
Chapter 1 Introduction
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Location in Text Original text Replacement or additional text
1  .1 Traffic medicine 
and the compilation 
of the guidelines
Additional Text The determination of the guidelines, 
and their annual review. is based on a 
number of factors, including likelihood 
of crash relating to factors associated 
with each illness, the importance 
of personal transport, fit with the 
practice and working of the Irish health 
services, European Union legislation and 
interdisciplinary perspectives. 
The perspective of both drivers and 
patients is incorporated through their 
review of the material processed 
through the Working Group: the 
incorporation of such perspectives is 
a topic which is not covered in the 
research literature on medical fitness to 
drive but thus far has been consensual 
in the development and review of the 
Irish guidelines. 
In addition, and consistent with good 
practice in guideline preparation , 
external review of the guidelines is 
undertaken by an international expert 
in the field. Finally, the NPOTM also 
reviews the utility and applicability of 
the guidelines with end users . 
The NPOTM is joint-funded by the 
Road Safety Authority and RCPI, the 
preparation and review process of these 
guidelines is editorially independent 
from both bodies.
1 .1 Traffic 
medicine and the 
compilation of the 
guidelines 
Additional Text …to diabetes, epilepsy vision 
,neurological diseases and obstructive 
sleep apnoea syndrome, have the force 
of law, by virtue of the confirmation of 
the 2009 Directive and 2014 Directives 
into regulations 12 and 20 of the 
Road Traffic (Licensing of Drivers) 
Regulations 2006, Statutory Instruments 
Number 537 of 2006, as amended by 
the Road Traffic (Licensing of Drivers) 
(Amendment) (No.) Regulations 2010, 
Statutory Instruments Number 544 of 
2010.These will be marked with an EU 
Symbol in the Guidelines.
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2 .3 Roles and 
responsibilities of 
health Professionals
Additional Text Underlying the professional obligation 
to manage risk and fitness to drive, 
there is also a professional and 
moral obligation to recognise and 
support mobility through appropriate 
diagnosis, treatment and support, as 
the consequences of driving cessation 
can lead to serious health, mobility and 
quality of life concerns as well .
2 .3 Roles and 
responsibilities of 
health Professionals
Additional Text In the case of an incident illness 
which may affect driving ability, it is 
the responsibility of the healthcare 
professional attending the patient for 
the relevant care episode to advise the 
patient on medical fitness to drive.
2  .3  .3 Adverse 
patient reaction 
towards the health 
professional
Patient hostility toward the health 
Professional
Adverse patient reaction towards the 
health professional
2 .4 .1 Documentation Additional Text To aid the documentation of the 
assessment process, a Patient Advisory 
Form is available on the RSA and NDLS 
website…
3 .1 Considerations 
for Group 2 licensing
Additional text added to below 
In such cases, … level of medical 
standard applied. 
Note: 
In such cases, … level of medical 
standard applied, as determined by the 
relevant occupational health service.
3  .2 Requirements of 
the driving task
Additional Text The information is operated on by many 
cognitive and behavioural processes 
including short and long-term memory 
and judgement, which leads to decisions 
being made about driving
Table 2 Environment 
factors affecting 
driving performance
Addition text/bullet point The driver’s insight, self-regulation of 
health and driving, and prudence
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3 .6 Multiple 
conditions and age 
related change
Additional Text ...This may require careful consideration 
and specialist referral: options include 
specialist medical referral, occupational 
therapy assessment, and an on-road 
assessment... 
…Clinical assessment: 
The key considerations are: 
• Cognition (including attention, 
concentration, presence of 
hallucinations and delusions, insight, 
judgement, memory, problem-
solving skills, thought processing and 
visuospatial skills). 
• Motor function (including joint 
movements, strength and co-ordination) 
• Sensory (in particular visual acuity and 
visual fields but also cutaneous, muscle 
and joint sensation).
3  .9  .1 General 
guidance for 
prescription medicine 
and driving
Text bold for emphasis …and once the driver is stabilised on the 
treatment…
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3 .9 .2 The effects of 
specific medicine 
classes 
Medicinal cannabis
Additional text For the following psychoactive 
medications, the driver should be 
advised about concerns over sedation 
while initiating and changing treatment, 
and that driving should cease if such 
signs are noted: resumption should only 
recommence when such sedating side-
effecthave ceased.
Medicinal cannabis 
Medicinal Cannabis 
The Health Products Regulatory 
Authority (successor to the Irish 
Medicines Board) authorised, in July 
2014, by issue of a product license, an 
approved human medicine containing 
the active ingredients of cannabis which 
may be prescribed as treatment for 
symptom improvement in adult patients 
with moderate to severe spasticity 
due to multiple sclerosis (MS). The 
therapeutic indication is for patients 
with MS who have not responded 
adequately to other anti-spasticity 
medication and who demonstrate 
clinically significant improvement in 
spasticity related symptoms during 
an initial trial of therapy. Medicinal 
cannabis may impair judgment and 
performance of skilled tasks. Research 
however suggests that patients adapted 
to their medicinal dose generally, but 
not always, maintain their driving 
ability (Freidel, M., et al. “Drug 
resistant MS spasticity treatment with 
Sativex¨ add-on and driving ability.” 
Acta Neurologica Scandinavica (2014).). 
Patients should be advised about 
potential effects of the medication 
on their driving and also advised 
to self-monitor accordingly for any 
indications of impairment of driving 
particularly when they first start to 
take the medication and until they are 
established on a stable daily dose. 
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Chronic Neurological 
Disorders
Additional Text Some of these conditions may also 
impact on cognition, perception and 
affect.
Subarachnoid 
Haemorrhage 
Surgery Craniotomy 
Endovascular 
Treatment
on clinical recovery 
on clinical recovery 
on clinical recovery
if no residual disability 
if no residual disability 
if no residual disability
Chapter 2 Additional footnote Footnote 16
Appendix Chapter 2 Additional footnote Footnote 17
Chapter 2 Neurological disorders
Chapter 3 Cardiovascular disorder
Location in Text Original text Replacement or additional text
Implantable 
Cardioverter 
Defibrillator (ICD)
LVEF is > 35% LVEF is ≥ 35%
Location in Text Original text Replacement or additional text
5  .0 Useful resources 
Moved from Chapt 1 
to Chapt 10 Drivers 
with disabilities
Changes to text to reflect information 
available on both the RSA and NDLS 
website
RSA web resources: at Licenced 
Drivers – Medical conditions www .rsa 
.ie/ merged NDLS info notating any 
difference
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Chapter 4 Additional Footnote Footnote 19
Insulin Treated 
Group 1
• Must not have had more than one 
episode of hypoglycaemia requiring 
the assistance of another person in the 
preceding twelve months. 
• Must not have had more than one 
episode of severe hypoglycaemia 
requiring the assistance of another 
person in the preceding twelve months. 
Driver must notify NDLS
Appendix – Chapter 4 4 .2 Information for Drivers with 
Diabetes Treated by Other Non-Insulin 
Medication, Diet or Both
4 .2 Information for Drivers with 
Diabetes Treated by Other Non-Insulin 
Medication, Diet or Both (For Group 1 
and Group 2 Drivers)
Location in Text Original text Replacement or additional text
Psychiatry Chapter 
Mild Cognitive 
Impairment (MCI) 
Group 1
Additional Text Given that a significant proportion of 
people with MCI progress to dementia 
over time, yearly review of diagnostic 
status is recommended.
Location in Text Original text Replacement or additional text
Cannabis Additional text far left column 
description
The non-prescribed use of this drug and/
or the use of supra- therapeutic dosage 
constitutes misuse/ dependence for 
licensing purposes. 
The prescribed use of medicinal 
cannabis at therapeutic doses 
(MIMS/BNF/PIL), without evidence 
of impairment, does not amount to 
misuse/dependence for licensing 
purposes (although clinically 
dependence may exist).
Chapter 4 Diabetes Mellitus
Chapter 5 Psychiatric Disorders
Chapter 6 Drug and alcohol misuse and dependence
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Chapter 7 – Visual 
disorders
Additional text Bioptic telescope devices are not 
accepted for driving by the NDLS.
Appendix Exceptional 
cases
Change in text re assessment of
exceptional cases
…medical eye doctor, subject to strict
criteria:
Appendix Exceptional 
cases
In order to meet the requirements of 
European law, to provide a driving 
licence certificate for 1, 3 or 5 years
In order to meet the requirements of 
European law, to provide a driving 
licence certificate for 1, 3 or 10 years
Chapter 7 Visual Disorders
Location in Text Original text Replacement or additional text
Respiratory and 
Sleep Disorders-
Additional text added Including moderate or severe 
Obstructive Sleep Apnoea Syndrome 
causing excessive daytime/awake time 
sleepiness (while driving).
Respiratory and 
Sleep Disorders
Additional text – Group 1 Driving must cease until satisfactory 
control of symptoms has been 
attained with ongoing compliance 
with treatment, confirmed by medical 
opinion. 
Periodic Medical review, 1-3 year licence 
may be granted 
Driver must notify NDLS.
Respiratory and 
Sleep Disorders-
Change in text – Group 2 …compliance with treatment, confirmed 
by consultant specialist medical opinion
Chapter 8 Renal Disorders
Chapter 9 Respiratory and sleep disorders
No Amendments
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Miscellaneous 
Conditions and 
Drivers with 
disabilities
Miscellaneous Conditions and Disabled 
Drivers
Drivers with disabilities
Chapter 10 Miscellaneous Conditions and Drivers with disabilities
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